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Over the past 4 billion years or so, beginning in the primordial soup from which 
terrestrial life descends, Mother Nature has been molding matter into a seemingly endless 
number of combinations and searching among them for useful properties. Almost 
certainly, the vast majority of these atomic combinations have held little value to Her but 
every so often, a particular combination is found, a gem of perfect dimension or reactivity 
possessing an extraordinary quality. The quality imparts a value to this particular 
arrangement of matter and because of it the combination is allowed to persist along with 
all the other extraordinary combinations.  
Humanity has long coveted Mother Nature’s process and aspired to emulate Her. 
Counted among Nature’s wondrous creations are the polyketides and the eponymous 
polyketide synthase enzymes that assemble them.  As a class of natural products, 
polyketides display incredible properties and have found wide-spread use in society as 
antibiotics, cholesterol medications and cancer therapeutics. The enzymatic molecular 
machines that biosynthesize these miracles are just as impressive and are regarded with 
envy by human chemists for their ability to make sophisticated chemical agents with 
unrivaled precision under the mildest of conditions.  This work aims to inch forward our 
understanding of these exquisite assembly lines so that we may better understand and 
imitate Nature. 
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Chapter 1:  Introduction 
Since the identification of the 6-deoxyerythronolide B (6-dEB) polyketide 
synthase (PKS) almost 30 years ago, it has served as the core paradigm for understanding 
the structural and mechanistic principles governing polyketide assembly lines (Cortes et 
al., 1990; Donadio et al., 1991; Khosla et al., 2007).  Responsible for the biosynthesis of 
the aglycone precursor of the macrolide antibiotic erythromycin, the 6-dEB synthase is 
comprised of 29 distinct enzymatic domains grouped into 6 functional enzyme sets 
termed modules that each perform a 2-carbon extension of the polyketide main chain 
utilizing a methyl-malonyl-CoA extender unit (Figure 1-1). The subsequent elucidation 
of the architecture and operation of 6-dEB synthase became the foundational knowledge 
base of polyketide biology regarding the assembly line logic and modular structure 
inherent to these polyketide synthases (Khosla et al., 2007). Largely from work on the 6-
dEB synthase it was extrapolated that PKS modules are minimally comprised of an acyl-
transferase (AT), acyl carrier protein (ACP) and ketosynthase (KS) domain used 
respectively to catalyze the selection, transfer and condensation of CoA-tethered extender 
units onto a growing polyketide scaffold. In addition to these core domains, it was 
observed that PKS modules generally contain a variable number of non-requisite 
processing domains that confer the majority of the remarkable amount of chemical and 
functional variability seen within finished polyketide products. The processing domains 
found within the 6-dEB synthase are 6 ketoreductases (KR), 1 dehydratase (DH) and 1 
enoyl-reductase (ER) necessary for the sequential reduction, dehydration and saturation 
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respectively of the polyketide β-keto position after each module’s elongation step. In 
addition to this, a terminal thioesterase domain (TE) is used for simultaneous cyclization 
and chain cleavage (Figure 1-1). Within the 6-DEB synthase, the consecutive and 
predictable action of monofunctional domains produces a clear collinear relationship 
between synthase and product where by knowledge of one allows determination of the 
other. This collinearity principle is considered a hallmark of PKS biology and in no small 
part contributed to the excitement surrounding early PKS engineering efforts as 
researchers envisioned using recombinant synthases for the production of made-to-order 
polyketides (Khosla et al., 2007). 
Over the past decade, it has become increasingly clear that the organization 
observed in the erythromycin system is frequently not extendable to other more recently 
discovered synthases. Indeed, many of the crucial supposed tenets of polyketide 
biosynthesis ostensibly do not hold true for other systems. This is particularly true for the 
more recently discovered trans-AT synthases that do not obey the relative parsimony of 
module structure and chemistry seen in the more canonical cis-AT systems exemplified 
by the 6-dEB synthase (Figure 1-2). The classic minimal definition of a module often 
breaks down for many trans-AT synthases where modules are comprised of domains 
lacking functional KS or AT domains (Piel, 2010).  Additionally, though the traditional 
processing domains used during erythromycin biosynthesis have been well studied, many 
novel processing domains have since been discovered whose function obfuscates the 
collinear relationship between enzyme and product (Helfrich, 2016). In light of the 
existence of these systems, the classical model for polyketide biosynthesis for which the 
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6-dEB synthase is the prototype is but a simplified lens for viewing PKS structure and 
function. To gain a more complete understanding of the power of polyketide synthases 
there must be a focused effort on elucidating the unconventional and varied aspects of 
these amazing enzymes. 
The bulk of my graduate work has gone towards investigating structural and 
functional aspects of polyketide biosynthesis that are uncommon or divergent compared 
to the enzymes and associated chemistry found within the classical 6-dEB pathway.  As 
alluded to above, the 6-dEB synthase is a relatively simple example of a polyketide 
synthase and branching out into divergent systems we enable a fuller appreciation of the 
true scope and potential of polyketide synthases as well as what they can be engineered to 
do.  
In Chapter 2 and Chapter 3, an alternate route of methyl branch incorporation 
into polyketides is investigated.  Within the 6-dEB system, methyl branches from the 
macrolide core are introduced via the incorporation of methyl-malonyl-CoA extender 
units.  A less commonly employed method for methyl incorporation in polyketides is 
through the use of embedded SAM dependent methyltransferase (MT) domains. Chapter 
2 characterizes the in vitro activity of 6 MT domains from the cis-AT gephyronic acid 
biosynthetic gene cluster and unequivocally demonstrates that all 6 of the domains 
exclusively methylate β-ketoacyl-thioester substrates suggesting that within a modular 
context the point of operation of MT domains is only immediately after KS mediated 
condensation.  
 4 
 
Chapter 3 extends the work of Chapter 2 by kinetically characterizing trans-AT 
MT domains from the bacillaene, difficidin and macrolactin pathways. The work reveals 
that trans-AT MTs also are specific for β-ketoacyl substrates but display only modest in 
vitro kinetic properties when excised from the synthase.  
Chapter 4 is a detailed examination of the enigmatic split bimodules endogenous 
to many trans-AT synthases. Contrary to canonical cis-AT systems like the erythromycin 
synthase, many trans-AT synthases house modules that are split across adjacent 
polypeptides. Within cis-AT systems, modules are typically contained on a single 
polypeptide while trans-AT synthases frequently contain modules split across two 
polypeptides. These splits conform to a few general arrangements with the two most 
common being the type A and B split dehydrating modules that each feature a C-terminal 
KS domain followed by an N-terminal DH domain. Chapter 4 explores these mysterious 
split bimodules from a structural, bioinformatic and functional perspective and highlights 
several conserved features unique to them focusing the aberrant secondary structure of 
bimodule ketoreductase and dehydratase domains. The close look at these modules has 
helped clarify their novel features as well as the chemistry they perform and has 
implications for the future of pathway annotation and natural product validation.  
Chapter 5 details the structural characterization of a novel enzyme, the pyran 
synthase (PS) domain. PS domains are often used by trans-AT synthases for the 
installation of 5 and 6 membered ether rings into polyketide backbones.  The high-
resolution crystal structure of a pyran synthase domain from the ninth module of the 
sorangicin synthase provides insight into the mechanism of action of this domain and 
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highlights the high homology PS domains share with the ubiquitous DH domain.  
Structure guided mutagenesis of the PS domain implicates a catalytic mechanism 
dependent upon a histidine and asparagine catalytic dyad that respectively activate and 
stabilize a polyketide hydroxyl nucleophile for ring formation.  
The assembly-line nature of polyketide synthases combined with the potent 
bioactivity of their polyketide products makes them very appealing engineering targets 
for the development of new therapeutics.  Though considerable progress has been made 
in this regard, genetic and combinatorial manipulation of polyketide synthases has been 
slowed by an imprecise understanding of the complexity of these enzymes and the range 
of chemistry they catalyze. It has become clear that these intricate enzyme systems are 
more dynamic and selective than previously appreciated and it is only through the close 
dissection of them that we can come to understand them enough to harness their full 
catalytic power for the creation of new polyketide drugs. 
In Chapters 2 and 3 I cloned all constructs, purified all proteins and set up 
enzyme reactions jointly with the other primary author on the projects.  In Chapter 4 I 
performed all structural work pertaining to PksKR3 and assisted with bioinformatic 
analysis. In Chapter 5, I performed all experimental work with the exception of substrate 
synthesis. In all chapters I contributed to data analysis and manuscript preparation. 
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Figure 1-1: The 6-Deoxyerythronolide B Synthase. 
6-dEB forms the scaffold of the polyketide antibiotic erythromycin. 6-dEB is produced 
by a polyketide synthase endogenous to Saccharopolyspora erythraea.  The synthase 
consists of six modules that each perform a two carbon extension of the polyketide 
backbone using a methyl-malonyl-CoA derived extender unit.  Each module is defined by 
a ketosynthase: KS, acyltransferase: AT and acyl carrier protein: ACP that mediate 
polyketide chain extension. Each module also contains a variable set of processing 
domains: ketoreductase: KR, dehydratase: DH, enoyl-reductase: ER.   
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Figure 1-2: Cis-AT vs trans-AT Polyketide Synthases. 
In comparison to canonical cis-AT polyketide synthases such as the 6-dEB synthase, 
trans-AT systems are much more varied both in the organization of their modules as well  
as the chemistry they employ.  The rules governing trans-AT polyketide synthases are 
not as well understood as those governing their simpler cis-AT counterpart. 
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Chapter 2:  a-Methylation Follows Condensation in the Gephyronic 
Acid Modular Polyketide Synthase 
Adapted from Wagner D, et al. (2016) Chem Commun (Camb). 11, 2466-74.   
ABSTRACT 
C-methyltransferases (MTs) from modular polyketide synthase assembly lines are 
relatively rare and unexplored domains that are responsible for installing a-methyl 
groups into nascent polyketide backbones. The stage at which these synthase-embedded 
enzymes operate during polyketide biosynthesis has yet to be conclusively demonstrated. 
In this work we establish the activity and substrate preference for six MTs from the 
gephyronic acid polyketide synthase and demonstrate their ability to methylate both N-
acetylcysteamine- and acyl carrier protein-linked b-ketoacylthioester substrates but not 
malonyl thioester equivalents. These data strongly indicate that MT-catalyzed 
methylation occurs immediately downstream of ketosynthase-mediated condensation 
during polyketide assembly. This work represents the first successful report of MT-
catalyzed mono- and dimethylation of simple thioester substrates and provides the 
groundwork for future mechanistic and engineering studies on this important but poorly 
understood enzymatic domain. 
INTRODUCTION 
S-Adenosylmethionine (SAM)-dependent methyltransferases (MTs) constitute a 
broad class of enzymes that find frequent use in primary and secondary metabolism 
(Ansari et al., 2008; Liscombe et al., 2012). When embedded within Type I polyketide 
synthases (PKSs), MTs function to catalyze the formation of α-methyl branches on 
polyketide chains.2 The action of MTs within PKS modules provides both an alternative 
route to the α-methyl branched intermediates typically introduced by methylmalonyl-
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CoA specific acyltransferase (AT) domains as well as the primary route for generating 
gem-dimethyl functionality (Ishida et al, 2007; Shecnk et al., 2007). 
Polyketides comprise a major fraction of all known natural products, and the 
molecular factories responsible for synthesizing them represent long-standing targets of 
protein engineering efforts (Williams, 2013). The diversity of polyketides is remarkable, 
particularly in light of the few types of enzymatic domains and the simple building blocks 
employed in their assembly. A series of PKS modules, minimally comprised of a 
ketosynthase (KS) and an acyl carrier protein (ACP) [as well as an acyltransferase (AT) 
in cis-AT PKSs)], orchestrate two-carbon extensions of polyketide chains via 
decarboxylative condensations. Each module typically contains one or more processing 
domains, such as a ketoreductase (KR), dehydratase (DH), enoylreductase (ER), and C-
methyltransferase (MT) that act on the α-/β-carbons of intermediates to confer 
complexity to the often large, stereo-dense final products (Keatinge-Clay, 2012). Though 
considerable effort has been dedicated to characterizing the structure and function of PKS 
biosynthetic pathways, limited work has been performed on embedded MT domains 
(Winter et al., 2013; Miller et at., 2002). Consequently, their substrate specificities and 
timing within the catalytic cycle of PKS modules have remained mysterious (Poust et al., 
2015).  
Two routes for MT-catalyzed methyl incorporation into polyketides are plausible 
(Figure 2-1) (Poust et al., 2015). In the first and traditionally-accepted route, methylation 
immediately follows KS-mediated condensation (aided by the decreased pKa of the b-
ketoacylthioester intermediate).  Conversely, in the second route, mono- or 
dimethylation occurs on the ACP-bound malonyl extender unit prior to 
condensation. Recent experiments on modules containing MTs catalyzing gem-
dimethylation within the yersiniabactin and epothilone PKS pathways detected the 
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formation of dimethylmalonyl-ACP via tandem MS and showed them to be 
suitable substrates for the subsequent condensation reaction indicating that the 
second route may be operative within these pathways (Poust et al., 2015). 
RESULTS AND DISCUSSION 
To further elucidate the timing of embedded mono- and dimethylating MT 
domains, we purified and assayed the five monomethylating MTs and the one 
gem-dimethylating MT from the gephyronic acid biosynthetic pathway of 
Cystobacter violaceous (Figure 2-2) (Young et al., 2013). All six of these MTs 
display activity towards β-ketoacylthioester substrates but not towards equivalent 
malonyl thioester substrates, providing evidence that the first route is operative for 
both mono- and dimethylation within the gephyronic acid synthase. To obtain 
soluble protein for the five monomethylating MT domains in the gephyronic acid 
synthase, four MTs were cloned and purified as MT+KR didomains (labeled as 
GphMT1, GphMT2, GphMT3, and GphMT6 for simplicity) and one as an 
MT+ER+KR tridomain (GphMT4) (Figure 2-3). A sequence alignment of cis-AT 
MTs reveals that MT domains are typically embedded within the KR structural 
subdomain, and our studies indicate that the inclusion of this region may be 
necessary for MT expression (Figure 2-4). Despite its location within a non-
reducing module, the gem-dimethylating GphMT5 harbors a C-terminal region 
with striking sequence similarity to the KR structural subdomain (Figure 2-4). 
GphMT5 was assayed both as a discrete domain and in the context of its complete 
module (GphH). All six excised MT constructs and GphH were expressed in E. 
coli BL21(DE3) and E. coli K207-3 strains, respectively, and purified by Ni-NTA 
(nickel nitrilotriacetate) chromatography. 
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All monomethylating MTs were observed to catalyze the methylation of 3-
oxopentanoyl-S-NAC, 1, to afford 2-methyl-3-oxopentanoyl-S-NAC, 2, with 
varying degrees of conversion, ranging from 2-24% after 72 h (Figure 2-5). 
Notably, after 72 h, no methylation of malonyl-S-NAC or malonyl-CoA was 
observed by any of the five monomethylating MTs. Taken together, these data 
suggest that all MT-catalyzed monomethylation occurs exclusively via route 1 in 
the gephyronic acid biosynthetic pathway. Dimethylation of 1 to afford 2,2-
dimethyl-3-oxopentanoyl-S-NAC, 3, was not detected. With the exception of the 
MT+ER+KR tridomain, GphMT4, the KRs in each of the didomain constructs 
were capable of reducing 1 and 2 (Figures 2-6 and 2-7). 
Both the GphH module and the MT excised from it, GphMT5, are capable 
of dimethylating 1 to afford 3, albeit with low efficiency (Figure 2-8). Slightly 
higher conversion was observed for the GphH module, implying that the gem-
dimethylating MT is more active in the context of its surrounding domains. 
Notably, 2 was not detected from reactions with either GphH or GphMT5, 
suggesting that the second methylation event occurs quickly after the first. Neither 
GphH nor GphMT5 catalyzed a detectable amount of methylation of malonyl-S-
NAC or malonyl-CoA, suggesting that dimethylation, like monomethylation, 
occurs exclusively via route 1 in the gephyronic acid PKS pathway. 
To remove the generated S-adenosylhomocysteine (SAH) product, a 
potential inhibitor of MTs, we assayed the activity of each of the GphMTs in the 
presence of the E. coli SAH nucleosidase Pfs (Liscombe et al., 2012; Hendricks et 
al., 2004). Co-incubation of GphMTs with Pfs greatly increased conversion of 1 to 
2 by GphMT1 and GphMT6, with 95% and 85% conversion, respectively, after 72 
h (Figure 2-9). Scaled-up reactions with GphMT1 provided milligram quantities of 
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2 with isolated yields of 78%.  The inclusion of Pfs in GphH and GphMT5 
dimethylating reactions did not provide a significant increase in conversion, 
suggesting that the concentration of SAH generated from the lower conversion of 
substrate is at sub-inhibitory levels (Figure 2-10). 
To gain insight into the substrate tolerance of embedded PKS MT domains, 
we next assayed the most active domains, GphMT1 and GphMT6, with 2 
additional substrates of varying chain length, 3-oxohexanoyl-S-NAC, 4, and 3-
oxobutanoyl-S-NAC, 6 (Figure 2-11). Since 1 most closely mimics the natural 
substrate of GphMT1, the marked decrease in activity observed for both the larger 
substrate 4 and the smaller substrate 6 suggests that GphMT1 exerts a moderate 
degree of selectivity for molecules most closely resembling the natively 
encountered substrate. Similarly, the decreased conversion of 6 by GphMT6 
relative to the larger substrates 1 and 4 suggests that mild selectivity is again 
arising from protein-substrate interactions beyond the β-keto group. The 
preference of GphMT6 for larger hydrophobic substrates can be rationalized by its 
presence within the penultimate module. In aggregate, these results are similar to 
the recent kinetic characterization of the MT domain from the lovastatin synthase 
LovB in that despite showing a preference for compounds closely resembling the 
natural substrates, they are promiscuous enough to act on a variety of β-ketoacyl 
compounds (Cacho et a., 2015). 
It is conceivable that the methylation of small molecule substrate mimics 
may not accurately reflect the methylation of the natural substrates of MTs. 
Therefore, we examined the activities of two MTs towards their cognate holo-
ACPs bound either to a β-ketopentanoyl moiety or a malonyl extender unit. 
GphACP1 and GphACP6 (the cognate ACPs of GphMT1 and GphMT6, 
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respectively) were expressed in E. coli K207-3 to afford holo-ACP domains that 
were then thioesterified with either substrate 1 or malonyl-CoA. For both GphMT 
constructs a 14-Da mass increase was observed by HRMS analysis (Figure 2-12). 
MS/MS spectra confirm MT-catalyzed methylation occurred at the α-position of 
the diketide attached to the pantetheinyl arm on the conserved ACP serine. 
Consistent with the previous results, no mass increase was observed during 
methylation attempts of either of the malonyl-S-ACPs. The selective methylation 
of β-ketoacyl-S-ACPs provides further evidence that MT-catalyzed B-branching 
occurs via route 1 during gephyronic acid biosynthesis. 
CONCLUSION 
In closing, our results provide significant evidence that MT-catalyzed methylation 
immediately follows KS-mediated condensation in the gephyronic acid PKS pathway. 
The data also represents the first reported activity of mono- and dimethylating MTs 
excised from a modular PKS and helps to provide insight into the substrate promiscuity 
of embedded MTs as well as the order of chemistry performed by PKS processing 
domains. As it stands, the reported variability in the timing of α-branching presents MTs 
as unique, versatile domains within PKS pathways that requires further exploration 
(Poust, et al., 2015; Young et al., 2013). Additionally, the robust activity of several of the 
GphMT domains when coupled with Pfs activity, make them potential tools for the 
incorporation of α-branches into previously reported PKS biocatalytic platforms to allow 
a greater access to polyketide chemical diversity. 
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METHODS AND MATERIALS 
Cloning and Expression of MT Domains 
The DNA encoding all polypeptides was amplified using primers listed in table 2-
1 from Cystobacter violaceus or E. coli BL21(DE3) genomic DNA and inserted into 
pGAY28b, a ligation independent cloning vector constructed from pET28b (Gay et al., 
2014). E. coli BL21(DE3) transformed with the expression plasmid was inoculated into 
LB media containing 50 mg/L kanamycin at 37 °C, grown to OD600 = 0.4, and induced 
with 0.5 mM IPTG. After 18 h at 15 °C, cells were collected by centrifugation and 
resuspended in lysis buffer (0.5 M NaCl, 10% (v/v) glycerol, 0.1 M HEPES, pH 7.5). 
Following sonication, cell debris was removed by centrifugation (30,000 x g, 30 min). 
The supernatant was poured over a column of nickel-NTA resin (Thermoscientific), 
which was then washed with 40 mL lysis buffer containing 15 mM imidazole and eluted 
with 5 mL lysis buffer containing 150 mM imidazole. The eluted protein was 
concentrated to ~10 mg/mL in the equilibration buffer and stored at -80 ˚C until needed. 
Substrate Synthesis 
3-oxopentanoyl-S-NAC (1), 2-methyl-3-oxopentanoyl-S-NAC (2), 3-
oxohexanoyl-S-NAC (4), and 3-oxobutanoyl-S-NAC (6) were synthesized as previously 
reported.2  
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In Vitro MT Reaction Conditions 
Reaction conditions for 200 µL monomethylating MT reactions: either 1 (10 
mM), 2 (10 mM) or malonyl-S-NAC (10 mM); Tris-HCl (150 mM); NaCl (100 mM); 
SAM (15 mM); GphMT (50 µM); and glycerol (10% v/v).  
Reactions conditions for 200 µL dimethylating MT reactions: either 1 (10 mM), 2 (10 
mM) or malonyl-S-NAC (10 mM); Tris-HCl (150 mM); NaCl (100 mM); SAM (30 mM); 
GphMT (50 µM); and glycerol (10% v/v).  
Reaction conditions for 200 µL monomethylating MT reactions containing Pfs: either 1 
(10 mM), 2 (10 mM) or malonyl-S-NAC (10 mM); Tris-HCl (150 mM); NaCl (100 mM); 
SAM (15 mM); Pfs (25 µM); GphMT (50 µM); and glycerol (10% v/v). High conversion 
of 1 to 2 was observed at 25-50 µM Pfs; Pfs concentrations below 25 µM provided lower 
conversions. 
Reactions conditions for 200 µL dimethylating MT reactions containing Pfs were 
as follows, either 1 (10 mM), 2 (10 mM) or malonyl-S-NAC (10 mM); Tris-HCl (150 
mM); NaCl (100 mM); SAM (30 mM); Pfs (25 µM); GphMT (50 µM); and glycerol 
(10% v/v).  
Reactions were run at ~25 °C for 24-72 h. After completion, reactions with diketide 1 
were extracted with 3 reaction volumes of EtOAc. The organic layer was dried in vacuo 
and resuspended in MeOH for HPLC analysis. After completion, reactions with malonyl-
S-NAC were heated to precipitate enzyme and centrifuged to clarify the supernatant for 
HPLC analysis.  
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Scaled 20 mL GphMT1 reactions: 1 (10 mM), Tris-HCl (150 mM); NaCl (100 mM); 
SAM (30 mM); Pfs (50 µM); GphMT (50 µM); and glycerol (10% v/v). Reaction was 
stirred at room temperature for 60 h and extracted with 3 volumes of EtOAc (3 x 20 mL). 
The EtOAc layer was washed with brine, dried over MgSO4, and concentrated in vacuo 
to provide a yellow oil that was purified via flash chromatography (75% EtOAc:hexanes) 
to provide 2 as a yellow oil (36 mg, 78%).  
Methylation of excised acyl-ACPs: Thiol reactions to produce acyl-ACPs were 1 
(5 mM), NaHCO3 pH 8.1(150mM), and GphACP(1/6) (50 µM).  Thiol reactions to 
produce malonyl-ACPs were malonyl-CoA (5 mM), NaHCO3 pH 8.1 (300mM), and 
GphACP(1/6) (50 µM). Thiol exchange were run at room temperature for ~30m. 
Following thiol exchange, Acyl-/malonyl-ACPs were collected with a 10 kDa spin filter. 
Methylation reactions to monitor methylation of excised ACPs were malonyl-/acyl-ACP 
(~10 µM), Tris-HCl (150 mM); NaCl (100 mM); SAM (10 mM); Pfs (20 µM); GphMT 
(20 µM) at room temperature for ~16h. Methylation reactions were first filtered with a 
30kDa spin filter to remove GphMTs and Pfs followed by a 10 kDa spin filter to collect 
malonyl-/acyl-ACPs for MS analysis. 
HPLC and HRMS Analysis 
HPLC conditions: All HPLC monitoring was performed on a tandem Waters 2707 
autosampler and Waters 1525 binary HPLC pump connected to a Waters 2998 
photodiode array detector using a Varian Microsorb-MV C18 column (250 x 4.6 mm, 5 
µm particle size, 100 Å pore size) and mobile phases consisting of water with 0.1% TFA 
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(solvent A) and acetonitrile with 0.1% TFA (solvent B) with a solvent gradient of 5%-
100% B over 30 min at a flow rate of 1 mL/min.  HRMS conditions: High-resolution 
mass spectrometry measurements were obtained by chemical ionization (ESI) with a VG 
analytical ZAB2-E instrument. HRMS & MS/MS conditions: All experiments were 
performed on a Thermo Fisher Scientific Orbitrap Elite mass spectrometer (San Jose, 
CA) modified with a 193 nm ArF excimer laser (Coherent ExciStar XS) to perform 
ultraviolet photodissociation (UVPD) experiments in the HCD cell. Protein solutions 
were loaded into Au-coated borosilicate emitters (10 µM in 50% (v/v) acetonitrile) and 
ionized offline using a nano-ESI source or by separation using a Dionex UltiMate 3000 
RPLC nanoLC system integrated with an ESI source. Chromatographic separations were 
performed using water (mobile phase A) and acetonitrile (mobile phase B), each 
containing 0.1% formic acid with a solvent gradient of 15% to 55% B over 45 min at a 
flow rate of 300 nL/min. The trap (30 mm × 0.1 mm) and analytical columns (with 
integrated emitter) (20 cm × 0.075 cm) were packed in-house using 5 µm Agilent PLRP-
S resin (1000 Å pore size). CID mass spectra were collected using normalized collision 
energy 25%. UV photoactivation of the modified proteins was achieved using one pulse 
with energy 2 mJ/pulse. MS1 and MS/MS spectra (50-250 scans) were acquired at 240 K 
resolving power (at m/z 400). Processing of MS/MS spectra was performed using Xtract 
and ProSight 3.0 to identify fragment ions.  1H-NMR, HRMS and HPLC of MT reactions 
below (Figures 2-13 – 2-41) 
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Figure 2-1: Timing of methyltransferase domains. 
Potential routes for polyketide synthase methyltransferase-catalyzed α-methylation. In 
route 1 methylation occurs immediately after ketosynthase mediated condensation. In 
route 2 methylation precedes condensation using a malonyl-ACP extender unit as 
substrate. 
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Figure 2-2:  Methytransferases in gephyronic biosynthesis. 
(A) Model of the gephyronic acid synthase and structure of gephyronic acid. MT domains 
highlighted in red. (B) Polyketides containing α-methyl branches (red) installed by MT 
domains embedded within cis-acyltransferase PKSs. 
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Figure 2-3: SDS-PAGE of purified MT-containing PKS fragments.  
1) MW marker, 2) GphMT1, 3) GphMT2, 4) GphMT3, 5) GphMT4, 6) GphMT5, 7) 
GphH (phosphopantetheinylated), 8) GphH, 9) GphMT6,  10) Pfs. 
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Figure 2-4.   Multiple sequence alignment of cis-AT MTs. 
Myc = microcystin, Nda = nodularin, Gph = gephyronic acid, Cur = curacin, Epo = 
epothilone, and Ybt = yersiniabactin. ‘B1’ indicates first beta-strand of KR structural 
subdomain. The two subsequent black lines indicate SAM binding motif of MT domain 
and NADPH binding motif that begins the KR catalytic subdomain, respectively 
β1#
SAM#
SAM#
NADPH#
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Figure 2-5: GphMT activity. 
(A) HPLC traces monitoring 235 nm; red, 1 synthetic standard; blue, 2 synthetic 
standard; black, GphMT1 reaction after 72 hrs. All HPLC peaks collected and 
confirmed via HRMS. (B) Conversion of 1 to 2 catalyzed by 50 uM MT constructs 
and GphH with 10 mM 1 and 15 mM SAM. Error bars represent standard 
deviation calculated from triplicate data.   
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Figure 2-6: Gph KR activity. 
Reduction of 1 by GphMT constructs with relative conversions. In vitro reductions were 
run as previously reported. 
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Figure 2-7: Reduction of by KR-containing GphMT constructs.  
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Figure 2-8: Dimethylation activity of GphMT5. 
Conversion of 1 to 3 catalyzed by 50 uM GphH and GphMT5 with 10 mM 1 and 
30 mM SAM. Error bars represent standard deviation calculated from triplicate 
data. 
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Figure 2-9: GphMT activity with Pfs. 
Conversion of 1 to 2 catalyzed by 50 uM monomethylating GphMT constructs in 
the presence of 25 uM Pfs with 10 mM 1 and 15 mM SAM. Error bars represent 
standard deviation calculated from triplicate data. 
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Figure 2-10: GphMT5 activity with Pfs. 
Conversion of 1 to 3 via GphH and MT5 catalyzed dimethylation in the presence of Pfs. 
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Figure 2-11: Impact of chain length on GphMT1 and GphMT6.  
Activity using substrates 4 (A) and 6 (B) (10 mM) with 15 mM SAM, 50 uM MT, 
and 25 uM Pfs (Note the difference in y-axis scale). Error bars represent standard 
deviation calculated from triplicate data. 
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Figure 2-12: ESI-MS of MTs on ACP bound substrates. 
Deconvoluted ESI-MS (mass range 13590 – 13620 Da) of 
phosphopantetheinylated (A) GphACP1 and (B) GphACP6 bound to a 3-
ketopentanoyl group showing a 14-Da mass increase after the MT reaction. 
 
 
	
	
A
B
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Figure 2-13: 1H-NMR of methylated substrate. 
1H-NMR (400 MHz, CDCl3): 6.0 (s, broad, 1H), 3.8 (q, 1H), 3.4 (m, 2H), 3.1 (m, 2H), 
2.6 (m, 2H), 1.9 (s, 3H), 1.4 (d, J = 7.2 Hz, 3H), 1.1 (t, J = 7.1 Hz, 3H). 
 
 
 
 
 
O
S
O H
N
O
 31 
 
 
Figure 2-14: GphMT1 reaction HPLC trace 72 h without Pfs.  
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Figure 2-15: GphMT1 reaction HPLC trace 72 h with Pfs. 
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Figure 2-16: GphMT2 reaction HPLC trace 72 h without Pfs. 
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Figure 2-17: GphMT2 reaction HPLC trace 72 h with Pfs. 
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Figure 2-18: GphMT3 reaction HPLC trace 72 h without Pfs. 
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Figure 2-19: GphMT3 reaction HPLC trace 72 h with Pfs. 
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Figure 2-20: GphMT4 reaction HPLC trace 72 h without Pfs. 
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Figure 2-21: GphMT4 reaction HPLC trace 72 h with Pfs. 
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Figure 2-22: GphH module reaction HPLC trace 72 h without Pfs. 
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Figure 2-23: GphH module reaction HPLC trace 72 h with Pfs. 
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Figure 2-24: GphMT5 reaction HPLC trace 72 h without Pfs. 
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Figure 2-25: GphMT5 reaction HPLC trace 72 h with Pfs. 
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Figure 2-26: GphMT6 reaction HPLC trace 72 h without Pfs. 
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Figure 2-27: GphMT6 reaction HPLC trace 72 h with Pfs. 
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Figure 2-28: No Enzyme negative control HPLC trace 72 h without Pfs. 
 
 
 
 
 
77
77
77
U
U
22727
2722
2727
2727
2726
2728
2772
2777
2777
2776
2778
2772
2777
2777
2776
2778
2702
2707
2707
2706
2708
2772
sssssss
77772 77772 77762 77782 70722 70772 70772 70762 70782 77722 77772 77772 77762
O
S
O H
N
O
 46 
 
Figure 2-29: No Enzyme negative control HPLC trace 72 h without Pfs. 
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Figure 2-30:  HRMS of HPLC purified 2 generated from 1 via GphMT1. 
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Figure 2-31:  HRMS of HPLC purified 3 generated from 1 via GphMT5. 
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Figure 2-32: HRMS of HPLC purified 5 generated from 4 via GphMT6. 
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Figure 2-33:  HRMS of HPLC purified 7 generated from 6 via GphMT6. 
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Figure 2-34: ESI-MS acyl- phosphopantetheinylated GphACP1. 
ESI-MS of phosphopantetheinylated GphACP1 thioesterified with 3-oxopentanoyl-S-
NAC (A) before and (B) after MT reaction. Insets give expanded views of the 
deconvoluted spectra (mass range 13550-13700 Da) labeled with the monoisotopic 
masses and mass accuracies relative to the theoretical mass of the modified proteins. 
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Figure 2-35: GphACP1 MS/MS before and after MT reaction. 
Deconvoluted MS/MS spectrum (mass range 350-380 Da) resulting from CID of the 15+ 
charge state of phosphopantetheinylated GphACP1 with 3-oxopentanoyl-S-NAC (A) 
before and (B) after MT reaction. Highlighted peaks correspond to the thioesterified 
phosphopantetheine moiety cleaved from the protein upon collisional activation labeled 
with the monoisotopic mass and mass accuracy relative to the theoretical mass. 
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Figure 2-36:  GphACP1 with 2-methyl-3-oxopentanoyl-S-NAC MS/MS. 
Deconvoluted MS/MS spectrum resulting from UVPD of the 15+ charge state of 
phosphopantetheinylated GphACP1 with 2-methyl-3-oxopentanoyl-S-NAC. Two 
possible modification sites were identified (Ser77 or Ser80) based on mass shifts in the 
observed fragment ions. 
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Figure 2-37:  ESI-MS of phosphopantetheinylated GphACP6. 
ESI-MS of phosphopantetheinylated GphACP6 thioesterified with 3-oxopentanoyl-S-
NAC (A) before and (B) after MT reaction. Insets give expanded views of the 
deconvoluted spectra (mass range 13500-13620 Da) labeled with the monoisotopic 
masses and mass accuracies relative to the theoretical mass of the modified proteins. 
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Figure 2-38:  GphACP6 MS/MS before and after MT reaction. 
Deconvoluted MS/MS spectrum (mass range 350-380 Da) resulting from CID of the 15+ 
charge state of phosphopantetheinylated GphACP6 with 3-oxopentanoyl-S-NAC (A) 
before and (B) after MT reaction. Highlighted peaks correspond to the thioesterified 
phosphopantetheine moiety cleaved from the protein upon collisional activation labeled 
with the monoisotopic mass and mass accuracy relative to the theoretical mass. 
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Figure 2-39:  GphACP6 with 2-methyl-3-oxopentanoyl-S-NAC MS/MS. 
Deconvoluted MS/MS spectrum resulting from UVPD of the 15+ charge state of 
phosphopantetheinylated GphACP6 with 2-methyl-3-oxopentanoyl-S-NAC. The 
modification was localized to Se74 based on mass shifts in the observed fragment ions. 
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Figure 2-40: ESI-MS of malonyl-phosphopantetheinylated GphACP1. 
ESI-MS of phosphopantetheinylated GphACP1 thioesterified with malonyl-CoA (A) 
before and (B) after MT reaction. The methylated form was not observed after the 
reaction. Insets give expanded views of the deconvoluted spectra (mass range 13550-
13700 Da) labeled with the monoisotopic masses and mass accuracies relative to the 
theoretical mass of the modified proteins. 
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Figure 2-41: ESI-MS of malonyl-phosphopantetheinylated GphACP6.  
ESI-MS of phosphopantetheinylated GphACP6 thioesterified with malonyl-CoA (A) 
before and (B) after MT reaction. The methylated form was not observed after the 
reaction. Insets give expanded views of the deconvoluted spectra (mass range 13500-
13620 Da) labeled with the monoisotopic masses and mass accuracies relative to the 
theoretical mass of the modified proteins. 
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Amplicon Forward Primer (5’ -> 3’) Reverse Primer (5’ à 3’) 
GphMT1 GCGGCCTGGTGCCGCGCGGCTCTAGCGCCGCGCTGCTCGACTC 
 
GTGGTGGTGGTGGTGGTGATGTTAAACCGGACGGGCGCGG 
 
GphMT2 GCGGCCTGGTGCCGCGCGGCTCTAGCGACGTCTCGCTGTTCGACG 
 
GTGGTGGTGGTGGTGGTGATGTTACGCGCGGATCCGG 
 
GphMT3 GCGGCCTGGTGCCGCGCGGCTCTAGCACGGCTGTGCAGGAGCCAC GTGGTGGTGGTGGTGGTGATGTTATTGCGGGAGGCCACCCA 
GphMT4 GCGGCCTGGTGCCGCGCGGCTCTAGCGCCGAGGGGCTCCAAGG GTGGTGGTGGTGGTGGTGATGTTACGATCCGCGCGACCAG 
 
GphMT5 GCGGCCTGGTGCCGCGCGGCTCTAGCGCCCCCGGCACTTTCG 
 
GTGGTGGTGGTGGTGGTGATGTTACTCGAGCGTGGCGAGCC 
 
GphHmod GCGGCCTGGTGCCGCGCGGCTCTAGCATGAGCAACGGGCAGTCGG 
 
GTGGTGGTGGTGGTGGTGATGTTATCACGTGCCCAGGAGCG 
 
GphMT6 GCGGCCTGGTGCCGCGCGGCTCTAGCGCCGTTGGCGCCGTC 
 
GTGGTGGTGGTGGTGGTGATGTTACGCGGCGGGACTCCC 
 
GphACP1 GCGGCCTGGTGCCGCGCGGCTCTAGCACGGCGGCTGAGCCC 
 
GTGGTGGTGGTGGTGGTGATGTTACACCTCGTCCATCAGCGC 
 
GphACP6 GCGGCCTGGTGCCGCGCGGCTCTAGCGCCAACCCGTCCGTGC 
 
GTGGTGGTGGTGGTGGTGATGTTACACCGGGACCTCGGG 
 
Pfs GCGGCCTGGTGCCGCGCGGCTCTAGCATGAAAATCGGCATCATTGGTG 
 
GTGGTGGTGGTGGTGGTGATGTTAGCCATGTGCAAGTTTCTGCAC 
 
 
 
Table 2-1: Primer sequences used for construction of all MT plasmids. 
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Chapter 3:  Methyltransferases Excised From trans-AT Polyketide 
Synthases Operate on N-acetylcysteamine-bound Substrates 
Adapted from Stevens, et al. (2016) J. Antibiot (Tokyo). 69, 567-570. 
ABSTRACT 
Trans-acyltransferase polyketide synthases are modular assembly lines employed 
by microbes to generate diverse, bioactive products. The methyl groups that branch from 
the polyketide scaffolds of these natural products are installed by synthase-embedded 
methyltransferases. While these methyltransferases greatly broaden the chemical space 
available to the polyketide natural products, they remain one of the least investigated 
processing enzymes of the modular polyketide synthases. Herein we examine the activity 
and selectivity of methyltransferases excised from the bacillaene, difficidin, and 
mupirocin synthases towards β-ketoacyl-S-N-acetylcysteamine analogs of their natural 
substrates. The results provide the first steps in the characterization of this class of 
methyltransferase as well as their development as biocatalysts. 
INTRODUCTION 
Trans-acyltransferase polyketide synthases (trans-AT PKSs) construct 
biologically active polyketides, such as the antibiotic mupirocin, in an assembly line 
process catalyzed by collections of enzymatic domains termed modules. Each module of 
a trans-AT possesses an acyl carrier protein (ACP) and ketosynthase (KS) that, along 
with a separately-encoded acyltransferase (AT) domain, constitute the minimal trio of 
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domains required for the extension of a covalently-bound intermediate (Piel, 2010; 
Helfrich et al., 2016). Further modifications at the α- and β-carbons of the polyketide are 
introduced by processing enzymes such as the methyltransferase (MT), ketoreductase 
(KR), dehydratase (DH), and enoylreductase (ER), depending on their inclusion within a 
module. This optional incorporation can be primarily credited for the vast chemical and 
functional diversity observed within polyketides. 
Unlike the embedded AT domains of cis-AT PKS pathways that deliver malonyl-
CoA or methylmalonyl-CoA extender units to a single module, the discrete ATs of trans-
AT PKSs deliver extender units to several modules. Since these ATs are primarily 
selective for malonyl groups, trans-AT PKSs employ embedded S-adenosyl methionine 
(SAM)-dependent MT domains to install methyl groups into polyketide backbones (Piel, 
2010; Helfrich et al., 2016; Keatinge-Clay, 2012). Although SAM-dependent MTs 
constitute a well-studied superfamily of enzymes and are relatively common within 
trans-AT PKSs, a dearth of information exists for trans-AT MTs and PKS-embedded 
MTs in general. Only a few studies of MTs from select cis-AT PKSs and fungal highly-
reducing PKSs (HR-PKSs) have been reported (Ansari et al., 2008; Lipscombe et al., 
2012, Miller et al., 2002; Poust et al., 2015). Analysis of a fungal HR-PKS responsible 
for the production of lovastatin revealed the kinetic preference of an embedded MT 
towards its native acyl-S-N-acetylcysteamine (SNAC) substrate analog (Miller et al., 
2015; Jenner at al., 2013; Jenner at al., 2015). 
To explore the selectivity of trans-AT MTs, we examined the methylation activity 
of excised MT domains from three well-known trans-AT pathways, responsible for the 
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production of the antimicrobial agents bacillaene, difficidin, and mupirocin (Figure 3-1), 
towards the acyl-SNAC substrates 3-oxobutanoyl-S-NAC (1), 3-oxopentanoyl-S-NAC 
(2), and 3-oxohexanoyl-S-NAC (3) (Moldenhaurer et al., 2010; Chen et al., 2006; Gurney 
et al., 2011). (Table 3-1). This is the first account of the substrate specificity and activity 
of excised MT domains from trans-AT PKSs. 
RESULTS AND DISCUSSION 
Expression of MT Domains 
Of the 7 domains cloned, all produced soluble protein with the exception of 
MupMT3.  In addition to several previously identified sequence motifs that distinguish 
between cis- and trans-AT MT domains, a trans-AT MT sequence alignment revealed an 
additional notable difference between these two classes of MT domain regarding their 
position of within the module (Young et al., 2013). In contrast to their cis-AT 
counterparts, trans-AT MTs are not embedded within the KR structural subdomain but 
are instead usually situated immediately after the KR domain and immediately before the 
ACP domain (Nguyen et al, 2008). 
Catalytic Activity of Excised MT Domains 
In vitro assays of the excised MTs BaeMT8, DifMT1, and MupMT1 showed each 
to be capable of catalyzing the methylation of substrates 1, 2, and 3 to afford 4, 5, and 6 
with 10-100% conversion observed after 16 h at 1-5 mM substrate concentrations (Figure 
3-2). These results show that, at least when separated from their assembly lines, MTs are 
not highly substrate-specific. Other excised PKS enzymes [KRs, DHs, ERs and 
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thioesterases (TEs)] also demonstrate broad substrate specificities (Young et al., 2013; 
Siskos et al., 2005). The low reaction rates of BaeMT8, DifMT1, and MupMT1 are 
suggestive that local substrate concentrations within the intact assembly line are required 
for optimal catalytic rates (Table 1). While the conversions of 1 to 4 catalyzed by 
BaeMT8 and DifMT1 as well as 2 to 5 catalyzed by BaeMT8 were observed overnight, 
the percent conversions within the linear region (1-3h) were too low to accurately report 
kinetic parameters using HPLC analysis. The observed reaction rates for MTs are lower 
than those of other excised processing domains (e.g., KRs, DHs, or TEs) towards N-
acetylcysteamine substrates (Li et al., 2014; Wang et al., 2008; Li et al., 2015; Zheeg et 
al., 2012). Although DifMT1 and BaeMT8 demonstrated substrate affinities for 2 and 3 
respectively (Table 3-1), a significant kinetic preference for a specific substrate was not 
observed from any of the investigated MTs. 
The N-terminal MTs DifMT6, DifMT13, and BaeMT12 did not catalyze a 
detectable amount of methylation of 1, 2, or 3. A partial misfold of the protein may have 
attenuated activity, this result suggests that, unlike the completely embedded MTs, N-
terminal MTs require additional components for activity, such as inclusion in their native 
polypeptide or interaction with the upstream PKS polypeptide. 
MATERIALS AND METHODS 
Materials 
S-adenosyl-methionine (Ark Pharm, Inc.) was dissolved in 300 mM sodium 
phosphate buffer (pH 7.8) to a final concentration of 150 mM. 
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Cloning and Expression of MT Domains 
The DNA encoding DifMT1, DifMT6, DifMT13, BaeMT8, BaeMT12, MupMT1, 
and MupMT3 was amplified from the difficidin and bacillaene gene clusters of Bacillus 
amyloliquefaciens FZB42 and the mupirocin gene cluster of Pseudomonas fluorescens 
13525 and inserted into pGAY28b, a ligation-independent cloning vector constructed 
from pET28b (Table 3-2) (Gay et al., 2015. E. coli BL21(DE3) transformed with the 
expression plasmid was inoculated into LB media containing 50 mg/L kanamycin at 37 
°C, grown to OD600 = 0.5, and induced with 0.5 mM IPTG. After 18 h at 15 °C, cells were 
collected by centrifugation and resuspended in lysis buffer (0.5 M NaCl, 10% (v/v) 
glycerol, 0.1 M HEPES, pH 7.5). Following sonication, cell debris was removed by 
centrifugation (30,000 x g, 30 min). The supernatant was poured over a column of 
Nickel-NTA resin (Thermoscientific), which was then washed with 40 mL lysis buffer 
containing 15 mM imidazole and eluted with 5 mL lysis buffer containing 150 mM 
imidazole. The eluted protein was concentrated to ~10 mg/mL in the equilibration buffer 
and stored at -80 ˚C until needed. The S-adenosyl-homocysteine (SAH) nucleosidase Pfs 
was amplified from E. coli BL21(DE3) genomic DNA and cloned and purified as above 
(Supplementary Table 1). Reactions were supplemented with Pfs due to the potent 
inhibition of MTs by SAH (Liscombe et al., 2012). 
Synthesis of Acyl-SNAC Substrates 
Compounds 1-3, 2-methyl-3-oxobutanoyl-S-NAC (4), and 3-oxohexanoyl-S-NAC 
(6) were prepared according to reported protocols, as was 2-methyl-3-oxopentanoyl-S-
NAC (5) (Piasecki et al., 2011; Bailey at el., 2016). 
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Kinetic Analysis of Methylation Activity 
To determine MT activity reactions with substrates 1-3 (10 mM) contained 150 
mM Tris-HCl, 100 mM NaCl, 20 mM SAM, 10% (v/v) glycerol, 20 uM Pfs, and 10 uM 
MT in a total volume of 200 uL. Reactions were run in parallel at 25 °C for ~16h. 
Standards of 4, 5, and 6 at concentrations from 250 uM-50 mM were added directly to 
injection solvent and HPLC peak areas were collected to provide standard curves for 
observable product formation. 
To determine the linear region of MT kinetic data reactions with substrates 1-3 
(10 mM) contained 150 mM Tris-HCl, 100 mM NaCl, 20 mM SAM, 10% (v/v) glycerol, 
20 mM Pfs, and 10 uM MT in a total volume of 200 uL and were run in parallel at 25 °C 
and quenched at Oh, 1h, 2h, 3h, 4h, and 5h time points. 
Reactions with substrates 1-3 (100 uM, 500 uM, 1mM, 2.5 mM, 5 mM, 10 mM, 
or 50 mM) contained 150 mM Tris-HCl, 100 mM NaCl, 20 mM SAM, 10% (v/v) 
glycerol, 20 uM Pfs, and 10 uM MT in a total volume of 200 uL. Reactions were run in 
parallel at 25 °C over a period of 1-3 hours (MupMT1+1, 1h; MupMT1+2, 2h; 
MupMT1+3, 3h; BaeMT8+3, 2h; DifMT1+2, 2h; DifMT1+3, 2h). After completion, 
reactions were extracted with 1 mL of ethyl acetate. The organic layer was dried in vacuo 
and resuspended in methanol for HPLC analysis. Standard curves were generated by 
HPLC analysis of 60 uM, 300 uM, 600 uM, 1 mM, 3 mM, and 6 mM injections of 4 
and 200 uM, 1 mM, 2 mM, 5 mM, 10 mM, and 20 mM injections of 5 and 6. Reactions 
for each set of substrate concentrations were performed in triplicate.  
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Product formation was quantified by absorbance with reverse phase HPLC 
resolution of reaction mixtures stopped at a fixed time-point with 0.1 – 50 mM substrate 
as well as full progress curves at 10 mM substrate (Figure 3-2 – 3-13). Global fitting of 
both data sets using using Kintek Explorer allowed determination of kcat/KM values for 
each enzyme/substrate pair (Johnson and Simpson, 2009, Johnson et al., 2009). 
HPLC and HRMS Analysis 
HPLC analysis was performed with a tandem Waters 2707 autosampler and 
Waters 1525 binary HPLC pump connected to a Waters 2998 photodiode array detector 
using a Varian Microsorb-MV C18 column (250 x 4.6 mm, 5 µm particle size, 100 Å pore 
size) and mobile phases consisting of water with 0.1% TFA (solvent A) and acetonitrile 
with 0.1% TFA (solvent B) with a solvent gradient of 5%-100% B over 30 min at a flow 
rate of 1 mL/min. High-resolution mass spectrometry measurements were obtained by 
chemical ionization (ESI) with a VG analytical ZAB2-E instrument. Peak integrations 
were automated with a signal-to-noise cutoff of 5% peak area. 
CONCLUSION 
The presented work demonstrates that, similar to the other processing domains 
excised from PKSs, excised trans-AT PKS MTs are capable of operating on thioester-
bound polyketide substrates in vitro. These data disclose the initial investigation of the 
heretofore unexplored MTs found throughout the trans-AT PKS landscape and provide 
insight into the catalytic activity of the enzyme when removed from its native module. 
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The ability of these MTs to install methyl branches on the carbon chains of small 
molecule substrates makes them particularly attractive as biocatalysts. 
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Figure 3-1: α-methylation catalyzed by trans-AT PKS MTs. 
(A) Canonical alpha-methylation catalyzed by trans-AT PKS MTs.  
(B) Methyl branches and cognate MT domains of bacillaene, difficidin, and mupirocin. 
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Figure 3-2: Methyltransferase saturation curves. 
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Figure 3-2: continued; 
Saturation curves for a) MupMT1 and 1, b) MupMT1 and 2, c) MupMT1 and 
3, d) BaeMT8 and 3, e) DifMT1 and 2, f) DifMT1 and 3. Experimental data from 
saturation curves globally fit to a fixed concentration time-course for enzyme- 
substrate pairs. 
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Figure 3-3: DifMT1 methylation activity of 3-oxopentoyl-S-NAC. 
HPLC traces monitoring 235 nm for, Top set: DifMT1 catalyzed methylation of 3-
oxopentanoyl-S-NAC (2) to afford 2-methyl-3-oxopentanoyl-S-NAC (5) at 500 uM (red) 
1 mM(orange), 2.5 mM (green), 5 mM (blue), 10 mM (violet) at 2h and Bottom set: 
DifMT1 catalyzed methylation of 3-oxohexanoyl-S-NAC (3) to afford 2-methyl-3-
oxohexanoyl-S-NAC (6) at 500 uM (red), 1 1 mM(orange), 2.5 mM (green), 5 mM 
(blue), 10 mM (violet) at 2h. 
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Figure 3-4: BaeMT8 methylation activity of 3-oxohexanoyl-S-NAC. 
HPLC traces monitoring 235 nm for BaeMT8 catalyzed methylation of 3-oxohexanoyl-S-
NAC (3) to afford 2-methyl-3-oxohexanoyl-S-NAC (6) at 500 uM (red),  1 mM 
(orange), 2.5 mM (green), 5 mM (blue) at 2h. 
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Figure 3-5: MupMT1 methylation activity of 3-oxobutanoyl-S-NAC. 
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Figure 3-5 continued; 
HPLC traces monitoring 235 nm for, Top set: MupMT1 catalyzed methylation of 3-
oxobutanoyl-S-NAC (1) to afford 2-methyl-3-oxobutanoyl-S-NAC (4) at 500 uM (red) 1 
mM (orange), 2.5 mM (green), 5 mM (blue), 10 mM (violet) at 1h; Middle set: MupMT1 
catalyzed methylation of 3-oxopentanoyl-S-NAC (2) to afford 2-methyl-3-oxopentanoyl-
S-NAC (5) at 500 uM (red)1 mM (orange), 2.5 mM (green), 5 mM (blue), 10 mM (violet) 
at 2.5h and Bottom set: MupMT1 catalyzed methylation of 3-oxohexanoyl-S-NAC (3) to 
afford 2-methyl-3-oxohexanoyl-S-NAC (6) at 500 uM (red) 1mM(orange), 2.5 mM 
(green), 5 mM (blue), 10 mM (violet) at 3h. 
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Figure 3-6: HPLC of DifMT1 conversion of 3-oxobutanoyl-S-NAC. 
HPLC trace monitoring 235 nm of DifMT1 conversion of 3-oxobutanoyl-S-NAC (1) to 2-
methyl-3-oxobutanoyl-S-NAC (4). 
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Figure 3-7: HPLC of BaeMT8 conversion of 3-oxobutanoyl-S-NAC. 
HPLC trace monitoring 235 nm of BaeMT8 conversion of 3-oxobutanoyl-S-NAC (1) to 
2-methyl-3-oxobutanoyl-S-NAC (4). 
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Figure 3-8: HPLC of BaeMT8 conversion of 3-oxopentanoyl-S-NAC. 
HPLC trace monitoring 235 nm of BaeMT8 conversion of 3-oxopentanoyl-S-NAC (2) to 
2-methyl-3-oxopentanoyl-S-NAC (4). 
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Figure 3-9: HRMS of MupMT1 reaction product 2-methyl-3-oxobutanoyl-S-NAC. 
HRMS spectrum for MupMT1 produced 2-methyl-3-oxobutanoyl-S-NAC (4). 
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Figure 3-10: HRMS of MupMT1 reaction product 2-methyl-3-oxopentanoyl-S-NAC. 
HRMS spectrum for MupMT1 produced 2-methyl-3-oxopentanoyl-S-NAC (5). 
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Figure 3-11: HRMS of MupMT1 reaction product 2-methyl-3-oxohexanoyl-S-NAC. 
HRMS spectrum for MupMT1 produced 2-methyl-3-oxohexanoyl-S-NAC (6). 
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Figure 3-12: Methyltransferase kinetic time course reactions. 
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Figure 3-12 continued: 
Time course data at 10 mM substrate for a) MupMT1 and 1, b) MupMT1 and 2, c) 
MupMT1 and 3, d) BaeMT8 and 3, e) DifMT1 and 2, f) DifMT1 and 3. Experimental 
data from concentration time-course was globally fit to a saturation-curve at a fixed time 
for enzyme-substrate pairs using KinTek Global Kinetic Explorer. 
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Figure 3-13: Kinetic model for MT activity. 
The kinetic model for in vitro methyltransferase reactions used to globally fit the data for 
all experiments using KinTek Global Kinetic Explorer. E=MT; E2=Pfs; SAM=S-
adenosylmethionine; SAH=S-adenosylhomocysteine; S=substrate; P=product; 
A=adenine. 
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Table 3-1: Kinetic analysis of DifMT1, MupMT1, and BaeMT8. 
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Table 3-2:  Primers used for MT plasmid construction. 
Primers used for PCR amplification of all methyltransferases assayed as well as the SAH 
nucleosidase PFS.  Ligation independent cloning regions highlighted in red. 
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Chapter 4:  Structural and Functional Trends in Dehydrating 
Bimodules from trans-Acyltransferase Polyketide 
Synthases 
Adapted from Wagner, et al. (2017) Structure. 25, 1045-1055. 
ABSTRACT 
In an effort to uncover the structural motifs and biosynthetic logic of the relatively 
uncharacterized trans-acyltransferase modular polyketide synthases (trans-AT PKSs), we 
have begun the dissection of the enigmatic dehydrating bimodules common in these 
enzymatic assembly lines. Here, we report the 1.98 Å resolution structure of a 
ketoreductase (KR) from the first half of a type B dehydrating bimodule and the 2.22 Å 
resolution structure of a dehydratase (DH) from the second half of a type A dehydrating 
bimodule. The KR, from the third module of the bacillaene synthase, possesses features 
not observed in other structurally-characterized KRs, including a longer active site loop 
preceding the catalytic tyrosine, differences in the NADPH-binding motif, and a helix 
that protrudes from the catalytic subdomain. The DH, from the tenth module of the 
difficidin synthase and the first DH to be structurally elucidated from a trans-AT 
assembly line, possesses residues that may enable α/β-cis, γ/δ-trans double dehydration 
as well as a large hydrophobic pocket on its surface that may mediate polypeptide 
docking for dehydrating bimodules that are split between two polypeptides. Correlations 
between the chemistries proposed for dehydrating bimodules and bioinformatic analysis 
indicate that type A dehydrating bimodules generally produce an α/ β -cis alkene moiety 
while type B dehydrating bimodules generally produce a α/β-trans, γ/δ-cis diene moiety; 
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however, completely accurate prediction of the intermediates generated by these 
dehydrating bimodules is not yet possible due to a mysterious isomerase activity. 
INTRODUCTION 
 Modular polyketide synthases (PKSs) are enzymatic assembly lines present in 
diverse bacterial species that produce bioactive molecules such as the antibiotics 
erythromycin and mupirocin (Hertweck, 2010). These PKSs have been distinguished as 
“cis-acyltransferase” and “trans-acyltransferase” (cis-AT and trans-AT) PKSs based on 
the reliance of the trans-AT PKSs upon separately-encoded ATs for selecting α-
carboxyacyl-CoA polyketide building blocks. While cis-AT PKSs, such as the 
erythromycin PKS, have been fairly well characterized both structurally and functionally, 
the trans-AT PKSs are largely uncharacterized owing to their more recent discovery 
(Keatinge-Clay, 2012; Piel, 2010; Helfrich and Piel 2016).  Beyond the eponymous 
distinction between these synthase types, trans-AT PKSs deviate from the colinearity 
rules much more often than cis-AT PKSs, such that the polyketides produced by trans-
AT PKSs cannot be confidently predicted by inspecting which enzymes are present 
within its modules [e.g., ketosynthase (KS), methyltransferase (MT), ketoreductase (KR), 
dehydratase (DH), enoylreductase (ER)] (Nguyen et al., 2008). 
Prominent among the colinearity-breaking domain organizations of trans-AT 
PKSs are the dehydrating bimodules (Figure 4-1). Frequent within trans-AT systems, 
they generally conform to one of two varieties, termed type A and type B (Moldenhauer 
et al., 2007; Piel, 2010; Helfrich and Piel, 2016). Each dehydrating bimodule type is 
usually split such that KS and DH of the second module reside in different polypeptides. 
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Type A dehydrating bimodules are usually correlated with the addition of two carbons in 
the form of an β-cis olefin and are comprised of KS, KR, acyl carrier protein (ACP), and 
a condensation-incompetent KS (KS+KRA+ACP+KS0) at the C-terminal end of the 
upstream polypeptide as well as DH and ACP (DH+ACP) at the N-terminal end of the 
downstream polypeptide (the KR subscripts indicate an A- or B-type KR, producing an L- 
or D-β-hydroxyl group, respectively) (Reid et al., 2003; Caffrey, 2003). Type B 
dehydrating bimodules are usually correlated with the addition of four carbons in the 
form of an α/β-trans, γ/δ-cis diene and are comprised of KS, KR, ACP, and KS 
(KS+KRA+ACP+KS) at the C-terminal end of one polypeptide and DH, ACP, and KR 
(DH+ACP+KRB) at the N-terminal end of the subsequent polypeptide. If the DH of type 
B dehydrating bimodules behaves as other characterized DHs, it would be expected to 
only dehydrate β-hydroxyacyl intermediates and thus operate first on the KRA-generated 
L-β-hydroxyacyl intermediate bound to ACP of the first module and then on the KRB-
generated D-β-hydroxyacyl intermediate bound to ACP of the second module. 
Fascinatingly, these DHs have recently been demonstrated to be capable of catalyzing the 
double dehydration of D-β-L-δ-dihydroxyacyl-ACP substrates (Challis, G., personal 
communication). 
trans-AT PKSs lack the canonical N- and C-terminal docking domains (NDD and 
CDD regions) that noncovalently join adjacent PKS polypeptides in cis-AT systems 
(Weissman 2006; Yan, 2009; Whicher, 2013), and the split nature of dehydrating 
bimodules is representative of the many uncharacterized disconnections between trans-
AT polypeptides. Recently, the most frequent docking mode for trans-AT polypeptides 
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was elucidated - docking motifs at the C- and N-termini that mediate polypeptide 
association through the formation of four-helix bundles (Dorival et al., 2016; Zeng et al., 
2016). However, the ordered assembly of trans-AT polypeptides occurs through other 
types of docking interactions, such as the noncovalent assembly of split enzymatic 
domains. The sequences at the polypeptide disconnections of split dehydrating bimodules 
indicate such a docking mode (Zeng et al., 2016).  
Here, crystal structures of enzymatic domains representative of both type A and 
type B bimodules are presented (Figure 4-1). The 1.98 Å-resolution structure of a KRA 
from a type A dehydrating bimodule of the bacillaene PKS (PksKR3) reveals features not 
observed in other structurally-characterized KRs, including a longer loop preceding the 
catalytic tyrosine, a shorter lid helix, a different NADPH-binding motif, and a helix that 
protrudes from the catalytic subdomain (Butcher et al., 2007; Straight et al., 2007). The 
2.22 Å-resolution structure of a DH from a type B dehydrating bimodule of the difficidin 
PKS (DifDH10), the first reported of a trans-AT PKS DH, reveals features, such as a 
histidine that may help catalyze an α/β, γδ-double dehydration as well as a hydrophobic 
cleft that may play a role in polypeptide docking (Chen et al., 2006). Correlations 
between the chemistries proposed for dehydrating bimodules and bioinformatic analysis 
indicate that type A dehydrating bimodules generally produce an α/β-cis olefin while 
type B bimodules generally produce a α/β-trans, γ/δ-cis diene; however, an 
uncharacterized isomerase activity still precludes accurate prediction of the intermediates 
generated by dehydrating bimodules. 
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RESULTS AND DISCUSSION 
Characteristics of dehydrating bimodules 
 To examine the composition of type A and type B dehydrating bimodules, 
representatives were aligned from the polypeptides of the bacillaene (abbreviations Bae 
and Pks represent the assembly lines from the Bacillus amyloliquefaciens FZB42 and 
Bacillus subtilis str. 168, respectively), batumin, chivosazol, difficidin, elansolid, 
kirromycin, leinamycin, macrolactin, sorangicin, and thailandamide assembly lines (type 
A: BaeK/BaeL, BaeL/BaeM, Bat2/Bat3, DifG/DifH, PksK/PksL, PksL/PksM, SorH/SorI, 
TaiK/TaiL; type B: ChiC, ChiD/ChiE, ChiF, DifI/DifJ, ElaO/ElaP, KirAI/KirAII, 
KirAIV/KirAV, LnmI/LnmJ, MlnE/MlnF, of these the only dehydrating bimodules not 
split between polypeptides reside in ChiC and ChiF)(Piel, 2010; Helfrich & Piel, 2016; 
Butcher et al., 2007; Chen et al., 2006; Mattheus et al., 2010; Perlova et al., 2006; Teta et 
al., 2010; Schneider et al., 2007; Weber et al., 2008; Nguyen et al., 2008) (Figure 4-2). A 
third type of dehydrating bimodule (termed “type C” here) was also observed, equivalent 
to a type A dehydrating bimodule but followed by a DH-like domain that apparently 
functions as an isomerase interconverting α/β-cis, δ/γ-trans dienes with α/β-trans, δ/γ-
cis dienes (e.g., DifJ/DifK, BonA/BonB, SorA/SorB, see discussion in Predicting the 
Polyketide Intermediates Generated by Dehydrating Bimodules). 
Aside from the presence of KRBs at the C-terminal end of type B dehydrating 
bimodules, type A and type B dehydrating bimodules are structurally quite similar 
(Figure 4-1). The first KS and the KS usually following the bimodule contain flanking 
subdomains, while the second KS does not (Gay et al., 2014a). The KRA present in both 
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bimodule types belongs to an unusual clade of KRs rarely observed in trans-AT PKSs 
outside of dehydrating bimodules. Both type A and type B dehydrating bimodule DHs 
lack ~20 residues observed at the N-terminal end of canonical DHs from trans-AT and 
cis-AT PKSs. 
Several of the domains within type A and type B dehydrating bimodules belong to 
distinct clades (Figure 4-2). This is not surprising for KSs, since KS clades are strongly 
correlated with the chemistry performed by the processing enzymes of the previous 
module (Nguyen et al., 2008). Thus, while the first KS of dehydrating bimodules can 
belong to several clades, the second KS is from clade XIV or XV (type A or B, 
respectively) and if a KS follows a dehydrating bimodule it belongs to clade XI or IX 
(type A or B, respectively). While the KRAs of type A and type B dehydrating bimodules 
clade together, the DHs belong to slightly different clades, possibly due to differences in 
their activities and docking interactions. While equivalent ACPs of type A and type B 
dehydrating bimodules seem to belong to the same clade, the ACPs from the first module 
of type A and type B dehydrating bimodules belong to a different clade than those from 
the second module. When tandem ACPs are present, as in ChiC, MlnG/MlnH, and 
MlnE/MlnF, they clade together. The ACP of the second module of a type B split 
bimodule precede the KR domain, as does the ACP preceding the DH-like isomerase in 
type C dehydrating bimodules; this unusual ordering is also observed in trans-AT 
modules containing an embedded ER. 
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KRA Structure & Activity 
The structure of PksKR3 was solved to 1.98-Å resolution by molecular 
replacement using PksKR2 as a search model (PDB: 4J1Q)(Piasecki et al., 2014)(Figure 
4-2 and Table 4-1). Like previously structurally-characterized KRs from cis-AT PKSs 
(Keatinge-Clay & Stroud, 2006; Keatinge-Clay, 2007; Zheng et al., 2010; Zheng et al., 
2013a, Zheng et al., 2013b, Bonnett et al., 2013) and trans-AT PKSs (Piasecki et al., 
2014; Zeng et al., 2016), PksKR3 is comprised of an N-terminal structural subdomain 
(KRs) and a C-terminal catalytic subdomain (KRc), each possessing a Rossmann fold 
(Figure 4-3). The KRc includes a catalytic tyrosine, Y386, as well as the conserved active 
site lysine and serine residues, K371 and S347 (numbering based on first observable 
residue). Complete density was observed for co-crystallized NADP+. 
Several features in PksKR3 are distinct from other solved cis- and trans-AT PKS 
KRs (Figures 4-3a-c, and 4-2). The NADPH binding motif is GGTRG(I/L)G rather than 
the typical motif GGxGG[I,L]G (Simunovic et al, 2006). The arginine of this motif, 
R228, makes ionic interactions with both the 2'- and 5'-phosphates of the nicotinamide 
cofactor, in contrast to an arginine in other solved KRs, located between βB and αC, that 
only contacts the 2'-phosphate (Figure 4-3c) (Keatinge-Clay, 2006). The glutamine three 
residues before the catalytic tyrosine (Q383), which in other KRs helps orient the 
polyketide substrate for stereoselective reduction through hydrogen bonding interactions 
with its thioester carbonyl, is itself oriented through a hydrogen bond with a carbonyl in a 
helical turn not present in other solved KRs (Mugnai et al., 2015; Keatinge-Clay, 2016). 
PksKR3 contains an extra β-strand in KRs compared to other structurally-determined 
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KRs as well as a shorter lid helix. Loop DE, which in B-type KRs contains the signature 
aspartate of B-type KRs, possesses the consensus sequence 
HCAGxxxxxx[P,L]AF[I,L]xK (residues 320-335) (Keatinge-Clay & Stroud, 2006). 
The most striking difference between PksKR3 and other structurally-characterized 
KRs is an ~15-residue motif that contains the consensus sequence LPPxxxW (residues 
255-271, ~25 residues C-terminal to the NADPH binding motif) and forms αBC, which 
makes very little contact with the rest of PksKR3 (Figures 4-3b and 4-3c). The LPPxxxW 
motif, conserved in KRs from dehydrating bimodules, is also present in many KRs 
following the adenylation (A) domains of non-ribosomal peptide synthetase (NRPS) 
modules and in the KRs from tubulysin modules 4 and 6 (Figure 4-4) (Hur et al., 2012; 
Sandmann et al., 2004). Interestingly, a C-methyltransferase (CMT) is present 
immediately C-terminal to this motif in tubulysin module 6. The structure of the CMT 
embedded in curacin module 7 (PDB: 5THZ) reveals how a partially conserved 
LPPDFLL motif at its N-terminal end fills in a hydrophobic groove (Skiba et al., 2016). 
Thus, the LPPxxxW motif could be the vestiges of a CMT that had inserted into a KR 
domain. 
The cis-double bond generated by type A dehydrating bimodules indicates that 
the first KR of type A and type B dehydrating bimodules is an A-type KR; also 
suggestive is that these KRs lack the signature aspartate of B-type KRs (Moldenhauer et 
al., 2010; Keatinge-Clay, 2016; Piasecki et al., 2013). To test this, PksKR3 was incubated 
with --ketopentanoyl-S-N-acetylcysteamine (NAC) in the presence of an NADPH 
regeneration system (Bacillus subtilis glucose dehydrogenase, D-glucose, and NADP+), 
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and the products were analyzed by chiral HPLC (Piasecki et al. 2011) (Figure 4-3d).  
Although NAC-bound substrates are shorter than natural ACP-bound substrates, they are 
often reduced equivalently to the natural substrate (Piasecki et al., 2011; Bailey et al., 
2016). For comparison, identical ketoreduction assays were performed with two well-
characterized KRs [the KR from the first module of the tylosin synthase (TylKR1) that 
generates (3R)-hydroxypentanoyl-S-NAC, and the KR from the fifth module of the 
mycolactone synthase (MycKR5) that generates the (3S)-hydroxypentanoyl-S-NAC in 
93% enantiomeric excess (ee)] (Piasecki et al., 2011). In agreement with the prediction of 
PksKR3 as an A-type KR, the major product was (3S)-hydroxypentanoyl-S-NAC (64% 
ee) (Figure 4-3). The assignment of PksKR3 as an A-type KR renders it the first A-type 
KR from a trans-AT PKS to be structurally characterized. All of the type A, B, and C 
dehydrating bimodules analyzed here possess this type of A-type KR within their first 
module. 
DH Structure & Activity 
The DH from the type B dehydrating bimodule of the difficidin synthase 
(DifDH10), was expressed, purified, and crystallized (Figures 4-5 and Table 4-1). Its 
structure was solved to 2.22-Å resolution by molecular replacement using a polyalanine 
model of the DH from the tenth module of the rifamycin synthase as a search model 
(PDB: 4LN9) (Gay et al., 2013). DifDH10 possesses a double hotdog fold similar to a 
recently-reported DH from a type A dehydrating bimodule (PksDH4, PDB: 5E1V), DHs 
from cis-AT PKSs (PDB: 3EL6, 3KG6, 3KG7, 3KG8, 3KG9), as well as the closely-
related branching (B) domain and enoyl-isomerase (PksEI16) (PDB: 4KC5, 
 95 
4U3V)(Keatinge-Clay, 2008; Akey et al., 2010; Bretschneider et al., 2013; Gay et al., 
2014). Unlike the dimeric DHs of cis-AT PKSs and the B domain, but like PksDH4 and 
PksEI16, DifDH10 crystallized as a monomer. 
When the DHs from split type A and type B dehydrating bimodules (PksDH4 and 
DifDH10) are compared with related domains, several differences are evident (Figures 
3a-e). The most striking deviation is that they possess ~20 fewer N-terminal residues. 
The HPLL motif present in DHs from both cis- and trans-AT PKSs occupies a 
hydrophobic pocket adjacent to α1 (Keatinge-Clay, 2008); with these residues absent, the 
hydrophobic pocket is exposed (Figures 4-5a and 4-5b). If the N-terminal DHs of split 
dehydrating bimodules mediate the association with the upstream polypeptide, then the 
residues at the C-termini of these polypeptides could complement the hydrophobic 
pocket. Indeed, semi-conserved residues are present following the C-terminal KSs of the 
first polypeptide of split type A and type B dehydrating bimodules and could enable these 
KSs to associate with N-terminal DHs to form a structure similar to the KS+B 
homodimer that was structurally elucidated from the rhizoxin assembly line (PDB: 
4KC5) (Figures 4-5a, 4-5b, and 4-7)(Bretschneider et al., 2013). 
The ~20-residue linker connecting the two halves of the DH double hotdog differs 
between the DHs of cis-AT and trans-AT assembly lines. The last portion of this 
sequence in the DHs of cis-AT assembly lines contains a conserved WPP motif that is 
replaced by a helical motif in the DHs of trans-AT PKSs (residues 126-134 in DifDH10). 
The first, third, and sixth residues of this motif are large hydrophobes while the second 
residue is most often an aspartate or asparagine that caps the helix (LDLSQIKAS in 
 96 
PksDH4 and LNIEAFMKN in DifDH10). As with the WPP motif, these hydrophobic 
residues contact a hydrophobic patch on the DH β-sheet. 
The active sites of PksDH4 and DifDH10 resemble all other structurally-
determined DHs with their catalytic histidine and aspartic acid equivalently oriented 
(H25 and D198 in DifDH10, numbering based on first observable residue) (Figure 4-5). 
However, the tyrosine of cis-AT DHs hypothesized to form a hydrogen bond with the β-
hydroxyl group of a substrate prior to dehydration (in a GYxYGPxF motif) is replaced by 
a histidine (termed H' here, H155 is 42 residues before the catalytic aspartic acid in 
DifDH10) and serves as a signature of DHs from dehydrating bimodules (Figure 3d) 
(Keatinge-Clay, 2008; Keatinge-Clay, 2016). H' seems to assume the role of the histidine 
or glutamine four residues after the catalytic aspartic acid in DHs from cis-AT assembly 
lines, forming a hydrogen bond with the aspartic acid (Figure 4-5c). Dehydration 
mediated by the DHs of type A dehydrating bimodules may proceed how cis-AT DHs are 
hypothesized to convert an L-β-hydroxyacyl substrate to a cis-α/β double bond-
containing product, with the aspartic acid donating a proton to the β-hydroxy leaving 
group and the histidine abstracting a proton from the L-α-hydrogen (Figure 3a) 
(Valenzano et al., 2010; Keatinge-Clay, 2016). The double dehydration mediated by the 
DHs of type B dehydrating bimodules on D-β-L-δ-dihydroxyacyl substrates is likely to 
first proceed how cis-AT DHs are hypothesized to convert a D-β-hydroxyacyl substrate to 
a trans-α/β double bond-containing product (Figure 4-5b) (Keatinge-Clay, 2016). How 
the second dehydration occurs is less certain. We propose that the thioester shifts towards 
the surface of the protein to form a hydrogen bond with a histidine conserved in DHs 
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from type B dehydrating bimodules (termed H'' here, in the HxxHGxxxxP motif); this 
would facilitate the abstraction of a proton from the L-γ-hydrogen by the same histidine 
that abstracted the proton from the L-α-hydrogen (HxxHGxxxxP) as the aspartic acid 
donates a proton to the L-δ-hydroxy leaving group to enable the second dehydration. To 
test the dehydrating activity of DifDH10, the substrate mimics crotonyl-S-NAC and (E)-
hex-2-enyl-S-pantetheine were assayed. Hydration of both compounds was observed 
(Figure 4-6). 
Predicting Dehydrating Bimodule Polyketide Intermediates 
Type A split bimodules usually produce α/β-cis olefins, and type B split 
bimodules usually produce α/β-trans, γδ-cis dienes. Some biosynthetic models for 
assembly lines containing split bimodules should be updated to reflect this. The type B 
dehydrating bimodules formed by DifI/DifJ and MlnE/MlnF from the difficidin and 
macrolactin assembly lines should each be shown producing an α/β-trans, γ/δ-cis diene. 
The biosynthetic model for the kirromycin assembly line is more challenging, since the 
α/β-trans, γ/δ-cis diene likely generated by the dehydrating bimodule formed by 
KirAIV/KirAV cannot be corroborated by the structure of kirromycin due to a 
downstream oxidation of the γ/δ-olefin (Weber et al, 2008). What most thwarts the 
accurate predifction of the polyketide intermediates, however, are mysterious 
isomerizations (Figure 4-7) 
The biosynthetic models for the kalimanticin (equivalent to batumin) and 
thailandamide assembly lines should seemingly be updated such that the type A 
dehydrating bimodule in each of them is shown generating a cis- rather than a trans-
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double bond as kalimanticin A and thailandamide B each contain a cis-double bond in the 
anticipated positions (Mattheus et al., 2010; Nguyen et al., 2008). However, kalimanticin 
B and thailandamide A are generated by the same assembly lines and each contain a 
trans-double bond in these positions. The trans-double bonds of kalimanticin B and 
thailandamide A may be generated through uncatalyzed cis-trans isomerization of 
kalimanticin A and thailandamide B; however, as discussed below, similar isomerizations 
from type B dehydrating bimodules actually appear to be catalyzed during polyketide 
synthesis. 
The biosynthetic models for the macrolactin and chivosazol assembly lines 
seemingly need to be updated such that the type B dehydrating bimodules formed by 
MlnG/MlnH and ChiD/ChiE are shown generating α/β-trans, γδ-cis dienes rather than 
α/β-cis, γδ-trans dienes (Schneider et al., 2007; Perlova et al., 2006). However, this 
would be inconsistent with the double bond geometries present within macrolactin and 
chivosazol. The type B dehydrating bimodule in the macrolactin assembly line is 
immediately followed by the macrocyclizing thioesterase (TE) that offloads the fully 
constructed polyketide, thus the type B dehydrating bimodule is apparently capable of 
generating an α/β-cis, γ/δ-trans diene. Perhaps the DH in this type B dehydrating 
bimodule is capable of interconverting an α/β-trans, γ/δ-cis diene with an α/β-cis, γ/δ-
trans diene. 
Consistent with this, DH-like isomerases seem to interconvert α/β-trans, γ/δ-cis 
dienes with α/β-cis, γ/δ-trans dienes in type C dehydrating bimodules. Examples appear 
in the assembly lines that produce bongkrekic acid, difficidin, and sorangicin (bimodules 
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formed by BonA/BonB, DifJ/DifK, and SorA/SorB) (Moebius et al., 2012; Chen et al., 
2006; Irschik et al., 2010). In each case an α/β-trans double-bonded intermediate (from 
trans-double bond-generating modules in the bongkrekic acid and sorangicin assembly 
lines and from a type B dehydrating bimodule in the difficidin assembly line) is passed to 
a type C dehydrating bimodule. After the installation of a cis-double bond by the type C 
dehydrating bimodule, the α/β-cis, γ/δ-trans diene is apparently interconverted with an 
α/β-trans, γ/δ-cis diene by the C-terminal DH-like enzyme. A downstream enzyme such 
as KS may select the isomerized intermediate. 
Insights into Assembly Lines from Dehydrating Bimodules 
This study of dehydrating bimodules raises more questions about trans-AT 
assembly lines than it answers. Type A dehydrating bimodules contain two more domains 
than a functionally equivalent module. Why dehydrating bimodules appear in place of 
canonical modules is unclear. That the vast majority of dehydrating bimodules are split 
between polypeptides even though they can exist on one polypeptide (e.g., ChiC, ChiF) 
indicates that the split confers an advantage, perhaps in terms of folding or evolution. 
Thus, this split may confer at least split dehydrating bimodules an advantage over 
canonical modules. 
The mode through which the polypeptides associate is informative. The current 
data support that the C-termini of the upstream polypeptides docks in the hydrophobic 
DH pocket filled by the HPLL motif in canonical DHs (Challis, personal 
communication). Split DHs have been observed to mediate polypeptide assembly in cis-
AT assembly lines, although the split is between the two hotdog subdomains (Amagai et 
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al., 2013). Essentially unique within trans-AT assembly lines to the first module of 
dehydrating bimodules, KRA could also play a role in polypeptide docking. If KRA 
assumed an orientation as shown in the model (Figure 4-8), the LPPxxxW motif and αBC 
would be close enough to contact the downstream, N-terminal DH. The study of the 
several modes through which trans-AT polypeptides dock is only in its infancy (Dorival 
et al., 2016; Zeng et al., 2016). 
CONCLUSIONS 
This study highlights the versatility of DH-like enzymes. The DHs of type A 
dehydrating bimodules apparently mediate two dehydrations to generate both trans- and 
cis-double bonds. They may also mediate the interconversion of α/β-trans, γ/δ-cis and 
α/β-cis, γ/δ-trans dienes as appears to be the role of the DH-like enzyme at the C-
terminal end of type C dehydrating bimodules. Other DH-like enzymes mediate double 
bond-shifting, either in the same site that catalyzed a dehydration or in an active site 
devoted to mediating the isomerization, as in the case of enoyl-isomerases (Moldenhauer 
et al., 2010; Gay et al., 2014). DH-like enzymes can even mediate pyran formation 
(Pöplau et al, 2013). The diverse chemistries catalyzed by these highly-related enzymes 
warrant mechanistic study. 
The KSs that follow the first and second modules of dehydrating bimodules 
belong to specific clades implicated in gatekeeping to ensure only specified chemistries 
are passed down the assembly line (Nguyen et al., 2008). The TE in the macrolactine 
assembly line may also be performing a gatekeeping function, only performing the 
cyclization of the α/β-cis, γ/δ-trans isomer. Studies to understand the mechanisms of 
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gatekeeping and the range of intermediates from which the specified intermediate is 
selected will further reveal the functional details of trans-AT assembly lines. 
EXPERIMENTAL PROCEDURES 
Cloning, Expression, and Purification 
PksKR3 was amplified from B. subtilis str. 168 genomic DNA with primers: 5'- 
GCGGCCTGGTGCCGCGCGGCTCTAGCTCAGAAAGAGACAAAAAAGAACTG -3' 
and 5'- GTGGTGGTGGTGGTGGTGATGTTATCCATCACATTTGGAAACTTC-3' 
(homology region for ligation independent cloning indicated in italics) and cloned into 
expression plasmid pGAY28b (Gay et al., 2014c). The construct encoded for residues 
3954 – 4459 of the PksK protein, with domain boundaries chosen based on previously 
solved KR structures. DifDH10 was amplified from Bacillus amloliquefaciens FZB42 
genomic DNA with primers: 5'-
AAGGTTCAACATATGGCAGTTGCCACCGATCAAGTCAAAACG -3' 
and 5'- TTGAACCTTCTCGAGATGGGTAATCATATTCGCTTGTCTGACCCT - 3' 
(NdeI and XhoI restriction sites indicated in italics). Domain boundaries were determined 
via comparing DifDH10 to EryDH4 (Keatinge-Clay, 2008). The amplicon was then 
digested with NdeI and XhoI and ligated into pET21a. The plasmids were then 
transformed into E. coli Bl21(DE3). 
For protein expression both for PksKR3 and DifDH10, E. coli BL21(DE3) cells 
transformed with the appropriate plasmid were grown to an OD600 of 0.5 in Luria broth 
containing 50 mg/L kanamycin at 37°C. The temperature was then dropped to 15°C prior 
to inducing protein expression with 0.5 mM IPTG, and grown for an additional 16 h. For 
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PksKR3, cells were collected via centrifugation at 4,000 x g for 15-30 minutes, 
resuspended in lysis buffer (400 mM NaCl, 50 mM HEPES pH 7.5, 10% glycerol), and 
lysed by sonication. Cellular debris was removed by centrifugation at 30,000 x g for 30 
minutes and the cell lysate was then poured over Ni-NTA resin (Qiagen) pre-equilibrated 
with lysis buffer. Bound protein was washed in 40 ml of lysis buffer containing 15 mM 
imidazole and eluted with lysis buffer containing 150 mM imidazole. An equilibrated 
Superdex 200 gel filtration column was used to buffer exchange the protein solution into 
150 mM NaCl and 10 mM HEPES pH 7.5. PksKR3 was concentrated to 11 mg/mL prior 
to crystallization trials. DifDH10 was purified identically with the exclusion of glycerol 
from the lysis, elution, and wash buffers. DifDH10. Prior to crystallization trials, 
DifDH10 was concentrated to 15 mg/mL. 
Crystallization and Structure Determination 
Crystals of PksKR3 grew in 2 days by sitting drop vapor diffusion at 22 °C. 
Drops were formed by mixing 2 μL protein solution (9 mg/mL PksKR3, 150 mM NaCl, 
10 mM HEPES, pH 7.5) with 1 μL crystallization buffer (sodium citrate, 0.1 M HEPES 
pH 7.0). Crystals were frozen in liquid nitrogen after a 20-min soak in the crystallization 
buffer modified with 10% (v/v) ethylene glycol. Diffraction data, collected at ALS 
Beamline 5.0.3, were processed by HKL2000 (Otwinowski & Minor, 1997). The 
structure was solved to 1.98 Å resolution by molecular replacement with PhaserMR 
(McCoy et al., 2007) in the CCP4 suite (Winn et al., 2011), using the KR1 monomer 
from the PksX synthase of B. subtilis (PDB code: 4J1Q) as the search model. The model 
generated from the molecular replacement solution was used to iteratively build into the 
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remaining electron density map with Coot (Emsley et al., 2010) and was refined with 
Refmac5 (Murshudov et al., 1997). The only regions that could not be modeled were 
residues 69-73 and 207-210. The first 14 and final 33 residues encoded in the PksKR3 
construct were absent in the x-ray structure. 
Crystals of DifDH10 were grown by the sitting vapor diffusion for 2 days at 22 
°C, in a equilibration solution of a 2:1 mix of protein solution (~15 mg/mL) and 
crystalization solution [26% PEG4000, 0.2 M lithium sulfate, 0.1 M Tris-HCl, pH 8.5]. 
Crystals were briefly soaked in cryoprotectant with 10% (v/v) glycerol added in the 
crystallization buffer and frozen in liquid nitrogen. The diffraction data, collected at the 
GM/CA beamline 23-ID-B at the Advanced Photon Source (APS, Argonne National 
Laboratory), were processed with iMosflm in the CCP4 suite. The structure was 
determined to 2.22 Å resolution by molecular replacement with PhaserMR using a 
polyalanine model of RifDH10 as the search model (PDB: 4LN9) (Gay et. al, 2013). The 
structure was solved in a primitive triclinic system with four chains in the symmetric unit. 
The model generated from the molecular replacement solution was refined with Coot and 
Refmac5. 
Substrate Synthesis 
3-ketopentanoyl-S-NAC: This KR substrate was synthesized as previously 
reported (Piasecki et al., 2011). (E)-hex-2-enyl-S-pantetheine: A solution of D-
pantetheine (90 mg, 0.35 mmol, 1 eq.) dissolved in 5 mL dichloromethane was cooled to 
4° C. To this solution was added (E)-hex-2-enoic acid (40 mg, 0.35 mmol, 1 eq.), 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide (67.1 mg, 0.35 mmol, 1 eq.), and 
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dimethylaminopyridine (4 mg, 0.035 mmol, 0.1 eq.) and was stirred at 4 °C for 1 h and at 
22 °C for another hour. Solvent was removed in vacuo, and the remaining material then 
purified via flash column chromatography (silica, 1:1 EtOAc:acetone) to afford (E)-hex-
2-enyl-S-pantetheine (100 mg, 81%) as a clear oil. The characterization was in agreement 
with a prior synthesis (Gay et al, 2013). 
DifDH10 Hydration Assay 
Hydration reactions were performed with 0.5 mM crotonyl-pantetheine, 0.25 M 
NaCl, and 150 µM DifDH10 in 25 mM HEPES buffer (pH 7.5) at a total volumne of 100 
uL at room temperature for 4 h. As a positive control, identical reactions were performed 
with 150 µM RifDH10 (Gay et al. 2013). Reactions were quenched by adding 50 µL of 
methanol. The reactions were then centrifuged at 20,000 x g for 8 min to remove 
precipitated protein. The samples were then analyzed on an Agilent 1200 Series HPLC 
coupled to an Agilent Technologies 6130 quadrupole mass spectrometer with an 
electrospray-ionization (ESI) source. A gradient of acetonitrile/water with 0.1% formic 
acid (5% - 95%) was run on an C18 reversed-phase analytical column (5 µm, 2 × 50 mm; 
Phenomenex) over 12 min at a flow rate of 0.7 mL/min and monitored at 230 nm. 
PksKR3 Reduction Assay 
Ketoreduction reactions were modified from a method described previously 
(Piasecki et al. 2011), with 5 mM 3-ketopentanoyl-S-NAC, 125 mM HEPES pH 7.5, 250 
mM NaCl, 200 mM D-glucose, 10% v/v glycerol, 200 μM NADP+, 1 μM glucose 
dehydrogenase (from B. subtilis str. 168), and 5 μM ketoreductase in a total volume of 
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500 μL The reactions were incubated overnight at room temperature (25 °C), extracted 
with ethyl acetate (3 x 500 μL) and dried in a speedvac. All samples were resuspended in 
ethanol prior to chromatographic analysis. Chiral chromatography was performed with a 
ChiraCel OC-H column (250 x 4.6 mm) with a Beckman Coulter System Gold 126 pump 
and a System Gold 166 PDA detector equipped with a 20μL loop. Absorbance was 
monitored at 235 nm. The solvent system used was 7% ethanol in hexanes (measured 
using volumetric flasks) at 0.8 mL/min. Enantiomeric excess was determined using peak 
area integrations. 
Accession Numbers 
Coordinates for PksKR3 and DifDH10 have been deposited in the PDB under 
accession codes 5KTK and 5KKU, respectively. 
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Figure 4-1:  Schematics of Type A and B Dehydrating Bimodules.  
(A) Type A dehydrating bimodules are typically split into polypeptides containing KS + 
KRA + ACP + KS0 and DH + ACP. The KS that follows the first module belongs to clade 
XIV, and a KS that follows the second module belongs to clade XI (Nguyen et al., 2008). 
The left side of the homodimeric assembly line shows which ACPs extend the growing 
polyketide, while the right side shows the hypothesized chemistry of the intermediates as 
they pass through the bimodule. PksKR3 is the KRA within the first module of the type 
A dehydrating bimodule formed by the polypeptides PksK/PksL from the bacillaene 
assembly line of B. subtilis 168.  
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Figure 4-1 continued; 
(B) Type B dehydrating bimodules are typically split into polypeptides containing KS + 
KRA + ACP + KS and DH + ACP + KRB. The KS that follows the first module belongs to  
clade XV, and a KS that follows the second module belongs to clade IX. DifDH10 is the 
DH within the second module of the type B dehydrating bimodule formed by the 
polypeptides DifI/DifJ from the difficidin assembly line of B. amyloliquefaciens FZB42. 
Asterisks show where the unsaturated moieties formed by the illustrated dehydrating 
bimodules appear in the fully synthesized natural product.  
 
 
 
 
 
 
 
 
 
 109 
 
 110 
 
 111 
 
 112 
 
 113 
 
 114 
 
!! !
 115 
 
!! !
 116 
 
!! !
 117 
 
!! !
 118 
 
 
 
 
 
!
!
!
!
! !
 119 
 
 
Figure 4-2: Comparing the Domains of Type A and Type B Bimodules. 
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Figure 4-2 continued; 
(A) The sequences of dehydrating bimodules (and the ensuing KS,  except  for  the  
MlnG/MlnH  bimodule,  which  is  followed  by  a  TE)  are  aligned.  
Type A and B dehydrating bimodules have equivalent domain architecture until the KRB 
of type B dehydrating bimodules. Domains are indicated with a line above the  
sequences colored as in Figure 1. Catalytic residues are indicated by asterisks, and motifs  
are  denoted  with  the  same  text  used  in  the  article,  except  for the  “LINKS”  
motif which is described elsewhere (Gay et al., 2016). BaeK/BaeL/BaeM, bacillaene, 
Bacillus  amyloliquefaciens,  CAG23957/CAG23958/CAG23959;  Bat2/Bat3,  batumin,  
Pseudomonas fluorescens, ADD82940/ADD82941; ChiC/ChiD/ChiE/ChiF, chivosazol,  
Sorangium  cellulosum,  AAY89050/AAY89051/AAY39052/AAY39053;  
DifG/DifH/DifI/DifJ,  difficidin,  Bacillus  amyloliquefaciens,  
CAG23978/CAJ57408/CAJ57409/CAJ57410;    ElaO/ElaP,  elansolid,  Chitinophaga  
sancti, AEC04361/AEC04362; KirAI/KirAII/KirAIV/KirAV, kirromycin, Streptomyces  
collinus,  AGS73523/AGS73524/AGS73526/AGS73527;  LnmI/LnmJ,  leinamycin,  
Streptomyces  atroolivaceus,  AAN85522/AAN85523;  MlnE/MlnF/MlnG/MlnH,  
macrolactin,  Bacillus  amyloliquefaciens,  
ABS73800/ABS73801/ABS73802/ABS73803; PksK/PksL/PksM, bacillaene, Bacillus  
subtilis,  WP_014476859/WP_014476860/WP_014476861;  SorH/SorI,  sorangicin, 
Sorangium  cellulosum,  ADN68483/ADN68484;  TaiK,  TaiL,  thailandamide,  
Burkholderia  thailandensis,  WP_009897624/WP_009897623.   
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Figure 4-2 continued; 
(B)  Sequence  Similarity Networks  show  the relationships between  the  domains  of  
type A and B  dehydrating  bimodules.    The Enzyme  Function  Initiative–Enzyme  
Similarity  Tool  was used to identify similarity between the equivalent domains of 
type A(blue) and type B (yellow) dehydrating bimodules (Gerlt et al., 2015). Cut off  
alignment scores are indicated. 
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Figure 4-3: KRA Structure and Function.  
(A) The 1.98 A˚ resolution structure of PksKR3 bound to NADP+ reveals the unusual 
architecture of KRAs from dehydrating bimodules. The structural subdomain (KRs)  
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Figure 4-3 continued; 
possesses an additional b strand, while the catalytic subdomain (KRc) possesses an 
additional a helix (aBC).   (B) The LPPxxxW motif associated with aBC is partially 
conserved throughout the dehydrating bimodules. Type A: BaeKR3/ BaeKR7, bacillaene, 
Bacillus amyloliquefaciens, CAG23957/CAG23958; DifKR4, difficidin, Bacillus 
amyloliquefaciens, CAG23978; PksKR3/PksKR7, bacillaene, Bacillus subtilis, 
WP_014476859/ WP_014476860; SorKR21, sorangicin, Sorangium cellulosum, 
ADN68483; TaiKR8, thailandamide, Burkholderia thailandensis, WP_009897624. Type 
B: ChiKR4/ChiKR12/ChiKR16, chivosazol, Sorangium cellulosum, 
AAY89050/AAY89051/AAY89053; DifKR9, difficidin, Bacillus amyloliquefaciens, 
CAJ57409; ElaKR6, elansolid, Chitinophaga sancti, AEC04361; KirKR1/KirKR11, 
kirromycin, Streptomyces collinus, AGS73523/AGS73526; LnmKR3, leinamycin, 
Streptomyces atroolivaceus, AAN85522; MlnKR7, macrolactin, Bacillus 
amyloliquefaciens, ABS73800. (C) A stereodiagram of KRc of PksKR3 reveals several 
features near the NADPH-binding site. The catalytic tyrosine (Y386) and active site 
residues K347, S371, and Q383 are oriented similar to other structurally characterized 
KRs, while the interactions of R228 with the nicotinamide cofactor have not been 
observed in other KRs. The LPPxxxW motif, which includes the protruding aBC have 
also not been previously observed. (D) PksKR3 reduces the model substrate 3-
ketopentanoyl-S-NAC as expected for the A-type mycolactone KR MycKR5 and not the 
B-type tylosin KR TylKR1 (Piasecki et al., 2011) 
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Figure 4-4: PksKR3 omit map and alignment of bimodule KRs.  
(A) Fo-Fc omit map of NADP+ cofactor and Y386 in PksKR3 active site.  
 (B) The unusual LPPxxxW motif of KRAs of trans-AT dehydrating bimodules, such as 
PksKR3, is also present in KRs from the tubulysin cis-AT PKS as well as KRs that 
follow A domains within NRPS assembly lines. A C- methyltransferase (CMT) inserts 
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Figure 4-4 continued; 
into TubKR6 imFmediately following the LPPxxxW motif. The structure of a CMT 
fromthe curacin  assembly line shows an LPPDFLL sequence at its N-terminus, 
suggesting that the LPPxxxW motif is the vestiges of a CMT (Skiba et al., 2016). 
AerKRL, aeroginosin, Microcystis aeruginosa, WP_069474084; AntKR2, antimycin, 
Streptomyces sp. S4, WP_010639240; HctKR2/HctKR4, Lyngbya majuscula, 
hectochlorin, AAY42397/AAY42398; PksKR3, bacillaene, Bacillus subtilis, 
WP_014476859; PyrKR4, pyridomycin, Streptomyces pyridomyceticus, WP_051829854: 
SpnKR2, splenocin, Streptomyces sp. CNQ431, WP_033947913; TubKR4/TubKR6, 
tubulysin, Archangium disciforme, CAF05649/CAF05651.  
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Figure 4-5: DH Structure and Function. 
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Figure 4-5 continued; 
(A) PksDH4 from the B. subtilis 168 bacillaene assembly line (PDB: 5E1V) is 
representative of DHs from the second module of split type A dehydrating bimodules. 
Stereodiagrams show an L-b-hydroxyacyl substrate modeled in its active site as well as 
the putative docking site for the C terminus of the upstream polypeptide. The catalytic 
histidine and active site aspartate (H and D) may perform dehydration of L-b-
hydroxyacyl substrates to a/b-cis double bonded products as proposed for DHs from cis-
AT assembly lines (Keatinge-Clay, 2016). (B) DifDH10 from the difficidin assembly line 
is representative of DHs from the second module of split type B dehydrating bimodules. 
Stereodiagrams show a D-b-hydroxyacyl substrate modeled in its active site as well as 
the putative docking site for the C terminus of the upstream polypeptide (with the 
exception of ChiC, which is not split but contains a similar motif). The catalytic histidine 
and active site aspartate (H and D) may perform dehydration of a D-b-L-d-dihydroxyacyl 
substrate to yield an a,b-trans double bond as proposed for DHs from cis-AT assembly 
lines. The histidine that abstracted the proton from the L-a-hydrogen could again abstract 
a proton from the L-g-hydrogen as the aspartate helps donate a proton to the L-d-
hydroxyl group, as shown in Route 1. A histidine conserved in DHs from type A 
dehydrating bimodules (H00) may be too distant to directly aid catalysis. The alternative 
Route 2 is based on how the DH in the final module of the ajudazol PKS is thought to 
mediate dehydration of a b-keto, d-hydroxy intermediate to yield a g/d-cis double bond. 
This relies on the presence of the b-keto group, which may positioned similar to a  
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Figure 4-5 continued; 
thioester carbonyl during canonical dehydration, and thus proceed before the reduction 
and dehydration that generates the a/b-trans double bond. (C) EryDH4 from the 
erythromycin assembly line (PDB: 3EL6) is representative of DHs from cis-AT assembly 
lines. Stereodiagrams show its active site with a Y in the same position as the signature 
H0 of DHs from dehydrating bimodules as well as the interactions of the N-terminal 
HPLL motif with the rest of the DH fold. The WPP motif of cis-AT DHs is replaced by a 
short helix in trans-AT DHs. (D) Sequences of DHs from split type A and B dehydrating 
bimodules, as well as canonical DHs from trans-AT and cis-AT assembly lines, are 
aligned. DHs from split dehydrating bimodules do not possess the HPLL motif of 
canonical DHs; the upstream C termini shown in (A and B) may dock to the same 
hydrophobic pocket as the HPLL motif (see Figure 4). The locations of the proton-
abstracting histidine (H), the signature histidine (H0) that replaces the tyrosine (Y) of 
canonical DHs, the histidine of type B dehydrating bimodules (H00), and the active site 
aspartate (D) are indicated. (E) A B domain from the rhizoxin assembly line (RhiB15, 
PDB: 4KC5) reveals how an HPLL motif completes the fold of that DH-like domain. The 
polypeptide immediately upstream of this motif also interacts with an N-terminal KS to 
rigidly connect the dimeric B domain with the dimeric KS. BaeK/BaeL, bacillaene, 
Bacillus amyloliquefaciens, CAG23957/CAG23958; Bat2, batumin, Pseudomonas 
fluorescens, ADD82940; ChiC/ChiD, chivosazol, Sorangium cellulosum, 
AAY89050/AAY89051; DifG/DifI/DifDH5/DifDH10, difficidin, Bacillus  
 
 129 
 
Figure 4-5 continued; 
amyloliquefaciens, CAG23978/CAJ57409/CAJ57408/CAJ57410; ElaO/ElaDH7, 
elansolid, Chitinophaga sancti, AEC04361/AEC04362; EryDH4, erythromycin, 
Saccharopolyspora erythraea, AAV51821; EsaX, uncharacterized, Enhygromyxa salina, 
KIG11581; GurX, uncharacterized, Geobacter uraniireducens, ABQ27263; KirAIV, 
kirromycin, Streptomyces collinus, AGS73526; LnmDH4, leinamycin, Streptomyces 
atroolivaceus, AAN85523; MlnE/MlnDH11, macrolactin, Bacillus amyloliquefaciens, 
ABS73800/ABS73803; PksK/PksL/PksDH4/PksDH5, bacillaene, Bacillus subtilis, 
WP_014476859/WP_014476860; RhiDH5, rhizoxin, Burkholderia rhizoxinica, 
CAL69889; RifDH10, rifamycin, Amycolatopsis mediterranei, WP_013222551; ScaX, 
uncharacterized, Streptomyces cattelya, WP_014144300; SorH/SorDH22, sorangicin, 
Sorangium cellulosum, ADN68483/ADN68484; TaiK/TaiDH9, thailandamide, 
Burkholderia thailandensis, WP_009897624/WP_009897623. 
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Figure 4-6:  DifDH10 omit map and dehydration assay. 
 
 131 
Figure 4-6 continued; 
(A) Fo- Fc omit map of active site residues H25 and D198 in the active site DifDH10.  
(B) DifDH10 was incubated with (E)-hex-3-enyl-S-pantetheine (1) for 4 h and analyzed 
as described. The LC/MS data, both in positive and negative modes, shows 
DifDH10 catalyzes the hydration of 1 to 2.  
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Figure 4-7: Model of a Dehydrating Bomodule. 
A stereodiagram shows a model for a split type B dehydrating module generated entirely 
from structurally elucidated trans-AT assembly line domains. The structure of PksKS2 
from the B. subtilis 168 bacillaene assembly line (PDB: 4NA1) was used for the first KS 
as well as for the KS following the bimodule, while the structure of the Rhi(KS + B)15 
didomain from the rhizoxin assembly line (PDB: 4KC5, without the flanking subdomain) 
was utilized for the KS of the second module (Gay et al., 2014a; Bretschneider et al., 
2013). The structure of the DH-like B domain RhiB15 (PDB: 4KC5) serves as a model 
for DH (Bretschneider et al., 2013). The structure of PksKR3 reported here represents 
KRA, and the structure of MlnKR6 from the macrolactin assembly line (PDB: 5D2E) 
represents KRB (Zeng et al., 2016). The structure of MupACP7a from the mupirocin 
assembly line (PDB: 2L22) provides templates for the ACPs (Haines et al., 2013). All  
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Figure 4-7 continued; 
domains except for the C-terminal KS and the N-terminal DH of split dehydrating 
bimodules are connected by flexible linkers as indicated by the schematic on the left. The  
location of the polypeptide split is circled in black. Interactions between the C terminus 
of the first polypeptide and a hydrophobic pocket in the N-terminal DH of the second 
polypeptide are hypothesized to facilitate docking.  
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Figure 4-8: Mysterious Isomerization.  
Accurate prediction of polyketide intermediates generated by dehydrating bimodules is 
thwarted by a mysterious isomerization activity. (A) This phenomenon is best illustrated 
in the macrolactin assembly line, where an offloading thioesterase (TE) immediately 
follows a type B dehydrating bimodule. The a/b-trans-g/d-cis diene anticipated from the  
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Figure 4-8 continued; 
type B dehydrating bimodule is apparently converted to a a/b-cis, g/d-trans diene prior to 
macrocyclization. Perhaps DH catalyzes this isomerization, and TE selects the isomerized 
intermediate for macrocyclization.  
(B) The interconversion of an a/b-cis, g/d-trans with an a/b-trans, g/d-cis diene is 
evidently mediated by a DH-like isomerase (labeled as DH0) in type C dehydrating 
bimodules. The KS following this isomerase may select the isomerized product for 
further elongation into a polyketide product such as bongkrekic acid. Asterisks show 
where the unsaturated moieties formed by the illustrated dehydrating bimodules appear in 
the fully synthesized natural product. 
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Table 1. Crystallographic  Parameters 
 
Data collection PksKR3  DifDH10  
Wavelength (Å) 1.0332 1.0332 
Space group P212121 P1 
Cell dimensions,  a, b, c (Å) 46.1, 84.9, 134.3 41.4, 74.0, 94.2 
Resolution (Å) 50.00 – 1.98 39.79 – 2.22 
Rmerge 0.082 (0.681) 0.104 (0.348) 
I/σ(I) 21.8 (2.3) 6.5 (1.5) 
No. of reflections 34,894 49,121 
Completeness (%) 97.1 (87.2) 89.5 (61.4) 
Redundancy 6.4 (5.6) 1.8 (1.4) 
Refinement     
Resolution (Å) 71.74 – 1.98 39.79-2.22 
No. of reflections 34,894 49,098 
Rwork/Rfree 0.214/0.241 0.217/0.249 
No. of atoms 3,811 9,816 
   Protein 3,560 9,353 
   Water 155 463 
Average B factors (Å2)      Protein 25 29 
   Water 36.37 31.62 
RMS deviations      Bond lengths (Å) 0.01 0.032 
   Bond angles (°) 0.1602 2.478 
Ramachandran Statistics (%)      Preferred Regions 97.53(435) 96.50 
   Allowed Regions 2.47(11) 3.50 
   Outliers 0 0 
 
Table 4-1: PksKR3 and DifDH10 crystallographic parameters. 
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Chapter 5: Structure and Activity of an Embedded Pyran Synthase 
Domain from a trans-Acyltransferase Polyketide Sythase 
ABSTRACT 
 trans-Acyltransferase polyketide synthases often utilize obscure enzymatic 
domains not generally observed in the biosynthetic pathways of their cis-acyltransferase 
counterparts. Within this repertoire of largely unexplored biosynthetic chemistry lies a 
novel class of pyran synthase that catalyzes the formation of 5 and 6 membered cyclic 
ethers within a variety of polyketide systems. The 1.55 Å crystal structure of an 
embedded pyran synthase domain from the enigmatic sorangicin pathway highlights the 
similarity of this enzyme to the ubiquitous dehydratase domain and reveals new insights 
into the mechanism of pyran ring formation.  Mutagenesis of active site residues 
corroborates the structural implications that together point toward a catalytic mechanism 
wherein the dehydratase catalytic dyad has been altered to create a novel active site 
centered around a conserved histidine as the sole residue directly involved in pyran ring 
formation. 
INTRODUCTION 
Polyketide natural products offer rich examples of the molecular complexity 
assembled by Nature from simple cellular metabolites. The sophistication of polyketides 
is realized through the action of the enormous modular mega-enzymes polyketide 
synthases (PKSs) (Keatinge-Clay, 2012). In prokaryotes, modular Type I PKS systems 
act as non-iterative assembly lines comprised of repeated multi-domain modules that 
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each perform a two-carbon extension and subsequent functionalization of a growing 
polyketide intermediate that ultimately produces a molecular scaffold that possessing 
exquisite bioactivity. The essential domains that define a module are the ketosynthase 
(KS), acyltransferase (AT), and acyl carrier protein (ACP) necessary for selection, 
transfer and condensation of extender units onto nascent polyketides.  A module also 
generally contains a sub-set of optional processing domains commonly including a 
ketoreductase (KR) for β-keto reduction, dehydratase (DH) for water elimination yielding 
an a/b-olefin and enoyl-reductase (ER) for reduction of the DH derived a/b-olefin 
(Keatinge-Clay, 2012).  Several less commonly employed domains, such as the 
methyltransferase (MT) are used to further expand polyketide diversity. 
Type I PKS systems are further eponymously classified as either cis or trans-
acyltransferase based on whether AT domains are encoded in-line or as discrete trans-
acting components that dock to the module(s) they supply extender units to.  For the trans 
systems in particular, much remains to be learned about their underlying chemical logic 
as well as the scope of chemistry they employ (Piel, 2009; Piel, 2016).  In addition to the 
traditional embedded domains they share with their cis-AT counterparts (KR, DH, ER, 
MT), trans-AT synthases often house domains of novel and poorly understood function 
involved in varied processes including O-methylation, β-keto methylation, double bond 
migration and pyran/furan ring formation.  In aggregate, these additional domains allow 
for greater chemical diversity within the trans-AT realm and contribute to the variety and 
bio-activity seen within trans-AT polyketides.  
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Of the novel enzymes unique to trans-AT biosynthetic gene clusters are pyran 
synthase (PS) domains.  Relative to cis-AT derived polyketides, trans-AT encoded 
molecules more commonly contain pyran and furan rings, due in part to their utilization 
of embedded PS domains dedicated to the installation of five- and six-membered ether 
rings onto polyketide backbones.  Though several examples exist of pyran containing cis-
AT polyketides such as ambruticin and salinomycin, they rely on machinery distinct to 
the PS domains harbored within trans-AT systems. In the case of cis-AT synthases, two 
separate routes to pyran rings are known.  In ambruticin biosynthesis, a bifunctional DH 
domain carries out a sequential dehydration and cyclization that leads to formation of a 
tetrahydropyran ring (Berkhan et al., 2014).  Remarkably, sequence level comparisons 
between AmbDH3 and typical mono-functional DH domains show no clear alterations to 
the active site architecture of AmbDH3 in comparison with the canonical DH His/Asp 
catalytic dyad retained in the expected orientation.  Alternatively, structural investigation 
of the post-PKS processing enzyme from the salinomycin pathway, SalBiii, has revealed 
it to be evolutionarily distinct from the dehydratase domain with high homology to an 
epoxide hydrolase/cyclase like family of enzymes (Luhavaya et al., 2015). Based on this 
homology SalBiii is currently hypothesized to employ a catalytic dyad consisting of two 
key aspartates that facilitate ether ring formation. 
Many trans-AT pathways use PS domains during polyketide biosynthesis to 
generate end products often possessing anti-proliferative or anti-microbial properties. 
Pathways utilizing PS domains include the pederin, psymberin, bryostatin, misakinolide, 
spliceostatin, ooocydin, thailanstatin and sorangicin systems with the thailanstatin and 
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sorangicin synthases encoding 2 and 3 PS domains respectively (Figure 5-1A). Of these 
domains, all naturally catalyze formation of a six-membered ring with the exception of 
the oocydin PS that produces a five-membered furan using a hydroxyl seemingly 
installed by a trans-acting monooxygenase (Matilla et al., 2012).  The relative paucity of 
furans likely at least in part stems from their requirement for non-KR derived hydroxyl 
nucleophiles. Notably, a putative PS domain within the thailanstatin NRPS-PKS hybrid 
pathway uses a threonine side-chain hydroxyl as a nucleophile in forming a six-
membered ring (Eustaquio et al., 2014; Zhang et al., 2011). It is presently unclear the 
extent to which PS domains display substrate specificity as well as if any distinction 
exists between five and six member ring forming PS domains.  
Previous work on the excised pyran synthase (PS) domains from the pederin and 
misakinolide biosynthetic gene clusters (BSG) demonstrated cyclization activity towards 
a/b– unsaturated N-acetylcysteamine (SNAC) substrates indicating that PSs act 
immediately after the DH domain during chain elongation (Poplau et al., 2013, Helfrich 
et al., 2015). NMR analysis of the purified products showed that with regard to the newly 
formed C-O bond, the pederin PS closes the ring robustly and stereoselectively in vitro 
making PS domains potentially useful as tools for the chemoenzymatic synthesis of 
cyclic ether moieties.  Although the evidence available suggests that PS domains close 
rings stereoselectively, inspection of the stereochemistry of the pyran rings within 
sorangicin A indicates that the 3 PS domains encoded by the BSG do not all add to the 
same side of their substrate’s site of unsaturation. Though no structural information on 
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embedded PSs exists, sequence alignment reveals high similarity to the canonical DH 
domain, ubiquitous among both cis- and trans-PKSs, with subtle deviations occurring at 
critical positions within the DH active site.  
The sorangicin pathway of Sorangium cellulosum is a large and poorly 
understood trans-AT pathway that generates antibiotics possessing potent broad-
spectrum activity (Irschik et al., 1987). The sorangicins are unique for their inclusion of 
three PS derived tetrahyropyran rings within their macrolide scaffolds (Figure 5-1A) 
(Irschik et. Al., 2010).  Bioinformatic analysis of the sorangicin BSG indicates that each 
of the three pyran rings is installed by a dedicated in-line pyran synthase domain. Though 
each PS domain is found within a slightly varied modular context (DH KS0PS ACP; KS 
DH PS KR ACP; KS DH PS --- KR ACP) they all are preceded by an active DH to 
provide them with the a/b–unsaturated substrate for the oxa-conjugate addition they 
catalyze (Figure 5-1B) (Zhang et al., 2017; Keatinge-Clay, 2017). Belying the 
considerable DH homology exhibited by PS domains, the Michael addition reaction they 
catalyze is mechanically distinct from the classic a/b-dehydration reaction that typifies 
the DH. Thus, the pyran synthase active site is hypothesized to have diverged in subtle 
ways in order to facilitate the intramolecular addition of a hydroxyl group across an a/b-
olefin instead of catalyzing the removal of water from across a double bond.  To shed 
light on the structural and mechanistic details of this as-of-yet un-elucidated enzyme, we 
report the first in class structure of a pyran synthase domain, SorPS9, from the ninth 
module of the sorangicin assembly line, alongside functional, mutational and 
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bioinformatic analysis of the SorPS9 active site. 
RESULTS AND DISCUSSION 
The identification of the boundaries of SorPS9 was accomplished via a multiple 
sequence alignment of several pyran synthase sequences alongside multiple structurally 
characterized dehydratase domains. This yielded the amino acid fragment consisting of 
residues 1360-1641 of the SorB polypeptide whose corresponding gene region was PCR 
amplified from purified S. cellulosum SoCe12 genomic DNA and cloned into the pET28b 
expression vector for protein purification & crystal screening trials. Diffraction of the 
optimized crystals yielded a 1.55 Å structure solved via molecular replacement using the 
CurDH8 structure (PDB: 3KG9) as a search model (Table 5-S1) (Akey, Structure 2010).    
Similar to other recently solved trans-AT DH-like domains SorPS9 crystallized as 
a monomer with its overall structure closely resembling the canonical DH architecture 
characterized by the double-hotdog fold topology (Figure 5-2A) (Akey et al., 2010; Gay 
et al., 2014 Zeng et al., 2016; Gay et al., 2013; Keatinge-Clay, 2008). Compared with 
recently solved trans-AT DH domains, MlnDH2 and RzxBDH (PDB: 5HST and 5IL6) 
SorPS9 displays RMSD Cα values of 1.4 Å and 1.6 Å, respectively, indicating that PS 
domains possess a high overall structural homology to trans-AT DH domains (Figure 5-
3).  The active site of SorPS9 however, contains several divergent features not observed 
in any dehydratase structure solved to date.  
Despite the irregularity of module nine of the sorangicin synthase, SorPS9 
appears representative of other PS domains with its novel features shared by other known 
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PS domains (Figures 5-1B, 5-1C & 5-4) (Eustáquio et al., 2014; Pöplau et al., 2013; 
Helfrich at al., 2015; Xavier et al., 2014).  The active site of SorPS9 is related to the 
prototypical DH active site, yet it contains distinct features in several critical aspects. 
Most notably, the highly-conserved His-Asp catalytic dyad used by the DH to facilitate 
water elimination is disrupted at the aspartate position in SorPS9 as well as other PS 
domains.  In the DH mechanism, the aspartate is hypothesized to act as a proton donor to 
generate the leaving water, but in SorPS9, an asparagine, N186, is found in its place 
(Figure 5-2).  Substitution at this position appears highly conserved for all PS domains 
but occasionally, as in the PSs harbored within the 16th module of the sorangicin 
synthase and the 9th module of the bryostatin pathway, a histidine is found at this 
position instead (Figure 5-4). Additionally, putatively assigned PS domains from the 
related thailanstatin and spliceostatin systems that lack other common PS motifs possess 
either a serine or phenylalanine at this position instead (Figure 5-5)( Eustáquio et al., 
2014).  Though the Cα of N186 superposes well with the aspartate backbone of the DH, 
the amide of the carbonyl side chain of SorPS9 is shifted closer to the catalytic histidine 
H33 (Figure 5-4B). This reorientation could allow hydrogen bonding with	 the	 ζ-hydroxyl	 group	 of	 the	 substrate	 or	 possibly	 with	 the	 imidazole	 of	 H33.	 H33	 and	N186	 reside in a large hydrophobic cleft devoid of other ionizable residues. The 
hydrophobicity of this environment may play a role in the exclusion of water or in 
decreasing the pKa of the catalytic histidine.  The scarcity of surrounding polar functional 
groups also limits the number of residues capable of participating in catalysis implying a 
mechanism primarily dependent upon H33 and N186. 
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Unique to PS domains is a four residue deletion within the HX8P motif conserved 
among all DH domains (Keatinge-Clay, 2008). The final proline of the motif is highly 
conserved among both PS and DH domains and is thought to stack against the catalytic 
histidine to align the imidazole for abstraction of the substrate α-hydrogen (Gay et al, 
2014).  The truncation to this motif occurs in an external loop immediately after the 
active site histidine but does not significantly alter the side-chain positions of H33 or 
P46. Despite this, the truncation does prevent the formation of 2 b-strands observed in 
other DH structures that form the back side of the PS active site (Figures 5-2, 5-4 & 5-3).  
The removal of this secondary structure may confer increased flexibility to the active site 
cavity to facilitate substrate rearrangement during cyclization. This deletion appears 
unique to and conserved across PS domains and is the only significant alteration to 
secondary structure that sets SorPS9 apart from DH domains. 
A structural alignment of SorPS9 with the recently structurally characterized 
trans-AT DH from Pseudomonas fluorescens (PDB:5IL6) and the enoyl-isomerase (EI), 
PksEI16 (PDB: 4U3V) from Bacillus subtilis reveals that SorPS9 possesses elements in 
common with both the DH and the EI (Gay et al., 2014; Kusebauch et al., 2010).  
SorPS9’s active site aspartate to asparagine substitution is also present in the PksEI16 
active site but its role in EI double bond migration is currently unclear. As the Asp to Asn 
mutation in PksEI16 superposes more closely with the Asp of the DH, N186 may have 
assumed a novel role during pyran ring formation (Fig 5-2 and 5-3). The imidazole side 
chains of the PS and DH catalytic histidines superpose with each other but in PksEI16 the 
catalytic histidine is shifted by ~1.7 Å which is postulated to be due to the absence of the 
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aforementioned conserved proline at the end of the HX8P motif. The absence of this 
proline seems to confer greater mobility to the catalytic histidine of PksEI16, facilitating 
its role as proton shuttle between the g-carbon and α–carbon.  This proline is retained 
within the PS truncated HX4P motif. restricting the movement of H33 within the active 
site.  A conserved HPLL motif is generally found at the N-terminus of all three domain 
types yet it is only the EI that is missing the b-strand that follows the HPLL motif. 
Bioinformatic inspection of KRs preceding PS domains suggests that all PS 
domains act on trans-a/b unsaturated intermediates. The configuration of the double 
bond acted upon by SorPS9 can be inferred from of the stereochemistry of the hydroxyl 
set by the upstream KR as hydroxyl orientation determines whether dehydration 
generates a cis or trans a/b-olefin.  Sequence analysis of KRs upstream of PS domains 
reveals that in almost every case the KR is that of a D-hydroxyl generating or B-type KR 
due to the presence of a diagnostic aspartate within the catalytic KR subdomain (Figure 
5-6) (Keatinge-Clay, 2007; Piasecki et al., 2014).  As DH domains eliminate B-type 
stereochemical products to trans olefins it seems that PS domains naturally act on trans-
a/b unsaturated substrates.  Ostensibly, SorPS9 seems an exception to this trend as the 
KR preceding it lacks the aforementioned diagnostic aspartate residue indicating it 
generates a b-D-hydroxy substrate that would give rise to a cis double bond after 
dehydration by the following DH. This anomaly is further supported by SorKR7’s 
presence within the C-terminal end of split dehydrating bimodule previously shown to 
invariantly contain a KRA in this position (Wagner et al., 2017).  Between SorKRA7 and 
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SorPS9 are two consecutive DH-like domains, the first of which almost certainly 
performs the elimination reaction generating the cis-olefin (Fig 5-1C).  The following 
DH-like domain contains several aberrant features including a cysteine in place of the 
critical aspartate that normally completes the DH catalytic dyad and the lack of the 
conserved proline hypothesized to orient the catalytic histidine and thus more closely 
resembles a diene isomerizing domain (DH0) rather than a traditional DH.  A sequence 
alignment corroborates this assignment showing that the putative SorDH08 shares the 
most homology with a domain from the bonkregic acid pathway involved in the 
interconversion of an a/b-cis-g/d-trans with an a/b-trans-g/d-cis diene (Figure 5-7) 
(Moebius Chem Biol, Wagner Structure).  This domain is bioinformatically distinct to the 
better characterized and seemingly more common enoyl-isomerase represented by 
PksEI16 that performs a a/b to b/g double bond migration mechanism (Gay et al., 2014). 
It thus appears that in Nature, PS domains exclusively receive a/b-trans-unsaturated 
substrates and that at least in the case of SorPS9, the upstream isomerization machinery 
was adopted as a requisite to pyran ring installation. 
To test the in vitro activity and selectivity of SorPS9 against a/b-unsaturated 
SNAC molecules we incubated the enzyme overnight with the anticipated PS substrate 1 
predicted to form a 6-membered ring.  After 16 hr. incubation at 25°C, LC-MS analysis 
of the reaction products revealed a near complete disappearance of 1 and the appearance 
of a new peak not observed in negative control reactions. Consistent with pyran 
formation, the new peak displayed an m/z ratio of 268 and a maximal absorbance shift to 
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234 nm from 260 nm as would be expected from the loss of a/b-conjugation with the 
thioester carbonyl that results from cyclization (Figure 5-8).  These results agree with the 
proposed role of SorPS9 in mediating pyran ring formation and further demonstrate the 
excised domain to be a robust and efficient in vitro biocatalyst.  When SorPS9 was 
incubated with the cyclized product of 1, no activity in the reverse direction was detected 
implying that equilibrium heavily favors the pyran ring formation (Figure 5-9). 
To probe the substrate tolerance of SorPS9, we next challenged the enzyme with 
the racemic secondary alcohol substrate 2, predicted to form a methyl substituted ring. 
The reaction was incubated as before with subsequent LC-MS analysis detecting two new 
peaks of roughly equivalent size. The appearance of these two equivalent peaks suggests 
that SorPS9 processes R and S secondary alcohols with a minimal preference for 
hydroxyl stereochemistry.   
Owing to the size and unsaturation of the natural substrate, SorPS9 likely has a 
tolerance for substitutions at the E-carbon and also to points of unsaturation along the 
substrate. This combination of the previously demonstrated stereoselectivity with regard 
to ether bond formation and substrate promiscuity towards a/b-unsaturated SNAC 
compounds could make SorPS9 an attractive tool in the chemoenzymatic synthesis of 
natural products containing pyran or furan rings.  
To better understand the roles of the two prominent conserved polar active site 
residues H33 and N186 in pyran ring formation the following point mutations were 
made: H33A, N186A, N186D and N186H.  All mutants produced soluble protein and 
were incubated as before with 1 and 2 and analyzed via LC-MS (Figure 5-10 and 5-11).  
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For both substrates, no discernable activity was detected for the H33A mutant consistent 
with its assignment as the critical base necessary for proton abstraction. The N186H 
mutant retained significant but reduced activity supporting its possible role as hydrogen 
bond donor to the substrate nucleophilic hydroxyl. The N186A and N186D mutants each 
displayed minimal and no activity, respectively, further corroborating this hypothesis. 
Together, these mutants demonstrate that although N186 is not essential for catalysis it 
plays an important role in the reaction and seems to contribute greatly to the overall rate 
of cyclization.  The complete abolition of activity observed for the N186D mutant further 
implies that N186 interacts with the substrate as a hydrogen bond donor since the 
introduction of negative charge in its place would be expected to create a 
thermodynamically unfavorable electronic interaction that would impede substrate 
binding.  A hydrogen bond with the substrate oxygen makes sense in the context of this 
mechanism as it would stabilize the substrate transition state during proton abstraction 
but when removed as in the case of the N186A mutant would not necessarily extinguish 
catalytic activity. 
The lack of potential catalytic residues within the SorPS9 active site allows for 
few possible players in the route to pyran ring formation.  The SorPS9 structure and 
mutagenesis results in combination with previous functional and structural work on 
related enzymes strongly suggest that SorPS9 catalysis is primarily dependent upon H33 
to mediate cyclization.  From the information available, it is highly probable that H33 is 
the sole residue directly participating in catalysis, acting to activate the ζ-hydroxyl and 
subsequently donate the hydroxyl-abstracted proton to the polyketide α-position to 
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complete the Michael addition reaction (Figure 5-8).  When substrate and product mimics 
are modeled into the SorPS9 active site cavity such that the ζ -hydroxyl is positioned in 
close proximity to H33 for proton abstraction the hydroxyl oxygen is within hydrogen 
binding proximity to N186 (~2.5 Å) (Fig 5-12B).  Though not strictly required for 
catalysis, N186 also plays a strong supporting role to H33, likely by acting as a hydrogen 
bond donor to the polyketide substrate ζ-hydroxyl. 
The high-resolution crystal structure of SorPS9 helps shed new light on the 
mysterious pyran synthase domains endogenous to many trans-AT polyketide synthases 
and highlights the high degree of homology PS domains share with the DH domain.  
Accompanying functional data demonstrate SorPS9 to be a robust in-vitro catalyst for the 
production of pyran rings with structure-guided mutagenesis implicating a single 
histidine as the only residue critical for catalysis. Structural comparison of PS to DH 
domains shows that slight alterations to DH active site architecture and overall secondary 
structure can lead to striking new types of chemistry. Indeed, modest alterations to the 
DH domain seem to have repeatedly repurposed it for new types of catalysis with 
structural and bioinformatic analysis suggesting it has served as a template for the 
evolution of novel PKS domains involved in polyketide cyclization, olefin shifting, 
cis/trans isomerization and vinylogous dehydration with at least one example of a tri-
functional domain existing (Gay et al., 2014, Fiers et al., 2016; Wagner et al., 2017;, 
Berkhan et al., 2014).  
The aberrant enzyme architecture, atypical domain ordering and novel chemistry 
within trans-AT synthases have hindered discernment of a coherent colinear relationship 
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between protein sequence and polyketide structure similar to what has been achieved for 
cis-AT systems.  As the integration of structural, functional and bioinformatic research 
methodology continues to demystify the numerous idiosyncratic features of trans-AT 
synthases the intricate relationship between synthase and polyketide will more clearly 
emerge.  To this end, the investigation of SorPS9 advances our understanding of the 
structures and chemistries hidden within the trans-AT realm and demonstrates how slight 
modifications to a malleable active site can expand the range chemistry performed by an 
enzyme family. Overall this work furthers the elucidation of trans-acyltransferase 
polyketide biosynthetic gene clusters that still possess a large untapped reservoir of 
biosynthetic potential. 
METHODS 
Cloning, Expression and Purification 
The gene-region corresponding to SorPS9 was amplified from Sorangium 
cellulosum Soce 12 genomic DNA, Gibson Assembled (New England Biolabs) into the 
pET28b expression vector and expressed heterologously in Escherichia coli BL21(DE3). 
N-terminal-hexahistidine-tagged SorPS9 was purified from cell lysate using immobilized 
metal affinity followed by gel filtration. Active site mutants of SorPS9 were generated 
using Gibson Assembly and standard site-directed mutagenesis techniques and primers 
(Table S2). Resulting protein was purified in a similar manner to wild-type. 
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Crystallization and Structure Determination 
Crystals of SorPS9 grew over 2–7 days by sitting drop vapor diffusion at 25 °C in 
a condition composed of 1.7 M ammonium sulfate and 0.1 M bis-tris (pH 5.5). The 
structure was initially solved by molecular replacement and the resulting model was 
further refined to 1.55 Å resolution using Arwarp, Refmac and Phenix Refine (Adams + 
Richardson, Langer et al., Winn et al., Murshudov et al.). The coordinates for SorPS9 
have been deposited in the Protein Data Bank, accession code 6B2V. 
Substrate Synthesis 
1A and 1B are commercially available (Figure 5-13). 
Synthesis of 1A and 1B could be performed from the following protocol: 
δ-valerolactone (1.0 g, 10.0 mmol) was dissolved in 30 ml dichloromethane, and 
then DIBAL-H 12 ml (1 M solution in hexane) was added at -78oC. The mixture was kept 
string for 2 hours until it was done. 3 ml methanol and then 10 ml saturated potassium 
sodium tartrate solution was carefully added to quench the reaction. The mixture was 
extracted by EtOAc 50 ml twice, and dried over Na2SO4. Precipitation Al(OH)3 could be 
removed by vacuum filtration. The solvent was removed by reduced pressure, and the 
crude 1A (470 mg, 40.5 %) was directly used for the next step without further 
purification as a sticky colorless oil. 
6-methyltetrahydro-2H-pyran-2-one (1.16 g, 10.0 mmol) was dissolved in 30 ml 
dichloromethane, and then DIBAL-H 12 ml (1 M solution in hexane) was added at -78oC. 
The mixture was kept string for 2 hours until it was done. 3 ml methanol and then 10 ml 
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saturated potassium sodium tartrate solution was carefully added to quench the reaction. 
The mixture was extracted by EtOAc 50 ml twice, and dried over Na2SO4. Precipitation 
Al(OH)3 could be removed by HCl wash. The solvent was removed by reduced pressure, 
and the crude mixture cis/trans-1B (248 mg, 21.4 %) was purified by column 
chromatography as a sticky colorless oil. 
Column condition: 3x7 cm.  
Eluant: 200 ml (9:1 EtOAc-hexane), then 100 ml pure EtOAc. 
Chen, S.H. Hong, B.C. Su, C.F. Sarshar, S. (2005) Tetrahedron Letters, 46(51), 8899-
8903. 
Synthesis 2A, 2B, 2C, and rac-2D (Figure 5-13) was adapted from the following 
protocol: 
J. Kennedy, N. J. Mccorkindale, R. A. Raphael (1061) A new synthesis of queen 
substance. J. Chem. Soc. 1961, 3813-3815.  
1A (470 mg, 4.60 mmol), malonic acid (530 mg, 5.09 mmol), 562 μl pyridine and 
30 μl propylamine were added together, and kept stirring overnight. The reaction mixture 
was then subjected to oil bath 105oC for 4 hours. The residue was poured into 2 ml 2M 
H2SO4 and extracted with diethyl ether 20ml and then 10 ml.  The organic phase was 
dried out over Na2SO4. The solvent was removed by reduced pressure. Purification of the 
residue via column chromatography gave 2A (171 mg, 25.7 %) as a sticky colorless oil. 
2A was described in the following protocol. 
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J. Kennedy, N. J. Mccorkindale, R. A. Raphael (1061) A new synthesis of queen 
substance. J. Chem. Soc. 1961, 3813-3815.  
Column condition: 1x7 cm. 
Eluant: 100 ml (1:1 EtOAc-hexane), then 100 ml pure EtOAc. 
1H NMR (400 MHz, Chloroform-d) δ 7.06 (dt, J = 15.6, 6.9 Hz, 1H), 5.83 (dt, J = 15.6, 
1.6 Hz, 1H), 3.66 (t, J = 6.1 Hz, 2H), 2.26 (qd, J = 7.1, 1.5 Hz, 2H), 1.72 – 1.46 (m, 4H) 
(Figure 5-14). 
HRESIMS m/z 148.9 (M-H2O+Na) (calcd for C7H10O2Na 149.06). 
1B (248 mg, 2.14 mmol), malonic acid (245 mg, 2.13 mmol), 260 μl pyridine and 
38 μl piperidine were added together, and kept stirring overnight. The reaction mixture 
was then subjected to oil bath 105oC for 4 hours. The residue was poured into 2 ml 2M 
H2SO4 and extracted with diethyl ether 20ml and then 10 ml.  The organic phase was 
dried out over Na2SO4. The solvent was removed by reduced pressure. Purification of the 
residue via column chromatography gave 2B (144 mg, 27.2 %) as a sticky colorless oil.  
NMR of 2B was confirmed by previous reference: J. Org. Chem., 1989, 54 (4), 911–914. 
Column condition: 1x7 cm. 
Eluant: 100 ml 1:1 EtOAc-hexane), then 100 ml pure EtOAc. 
1H NMR (400 MHz, Chloroform-d) δ 7.07 (dt, J = 15.6, 6.9 Hz, 1H), 5.84 (dq, J = 15.6, 
0.9 Hz, 1H), 3.82 (q, J = 6.1 Hz, 1H), 2.26 (td, J = 6.9, 1.4 Hz, 2H), 1.67 – 1.54 (m, 1H), 
1.57 – 1.42 (m, 3H), 1.30 – 1.17 (m, 3H) (Figure 5-15). 
HRESIMS m/z 163.1 (M-H2O+Na) (calcd for C8H12O2Na 163.07). 
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1A (138 mg, 1.35 mmol), malonic acid (155 mg, 1.49 mmol), 166 μl pyridine and 10 μl 
piperidine were added together, and kept stirring overnight. The reaction mixture was 
then subjected to oil bath 105oC for 4 hours. The residue was poured into 4 ml 1M HCl 
and extracted with diethyl ether 20 ml then 10 ml.  The organic phase was dried out over 
Na2SO4. The solvent was removed by reduced pressure. Purification of the residue via 
column chromatography gave mainly 2C (33 mg, 17.0 %) as a sticky slightly yellow oil.  
NMR of 2C was confirmed by previous reference: Synthetic Communications, 1988, 
18(15), 1757-62. 
Column condition: 1x8 cm.  
Eluant: 90 ml (1:2 EtOAc-hexane). 
1H NMR (400 MHz, Chloroform-d) δ 4.00 (dt, J = 11.5, 2.2 Hz, 1H), 3.78 – 3.68 (m, 
1H), 3.48 (td, J = 11.5, 2.9 Hz, 1H), 2.54 (dd, J = 15.5, 8.0 Hz, 1H), 2.46 (dd, J = 15.5, 
4.8 Hz, 1H), 1.84 (ddd, J = 11.3, 5.7, 2.3 Hz, 1H), 1.71 – 1.45 (m, 4H), 1.41 – 1.28 (m, 
1H) (Figure 5-16). 
HRESIMS m/z 145.1 (M+H) (calcd for C7H13O3 145.09). 
1B (573 mg, 4.94 mmol), malonic acid (557 mg, 5.36 mmol), 580 μl pyridine and 32 μl 
piperidine were added together, and kept stirring overnight. The reaction mixture was 
then subjected to oil bath 105oC for 4 hours. The residue was poured into 2 ml 8M 1M 
HCl and extracted with diethyl ether 25ml twice.  The organic phase was dried out over 
Na2SO4. The solvent was removed by reduced pressure. Purification of the residue via 
column chromatography gave mainly rac-2D (215 mg, 27.5 %) as a sticky slightly 
yellow oil.  
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NMR of rac-2D was confirmed by previous reference: T.L., 2016, 57 (1), 53-55. 
Column condition: 1x8 cm. 
Eluant: 90 ml (1:2 EtOAc-hexane). 
1H NMR (400 MHz, Chloroform-d) δ 3.77 (dtt, J = 10.8, 5.4, 2.4 Hz, 1H), 3.55 (ddd, J = 
11.1, 6.3, 1.9 Hz, 1H), 2.61 – 2.44 (m, 2H), 1.68 – 1.47 (m, 4H), 1.30 – 1.22 (m, 2H), 
1.20 (dd, J = 6.2, 3.8 Hz, 3H) (Figure 5-17). 
HRESIMS m/z 159.1 (M+H) (calcd for C8H15O3 159.09). 
Synthesis 3A, 3B, 3C and rac-3D (Figure 5-13) was adapted from the following protocol 
and the results were compatible as previously reported: 
Pöplau, P. Frank, S. Morinaka, B.I. Piel, J. (2013) Angew. Chem. Int. Ed. 2013, 52, 
13215-13218.  
EDC-HCl (384 mg, 2.00 mmol) was added to 2A (145 mg, 1.00 mmol) in 2.5 ml 
dichloromethane solution at 0oC under protection of argon. The reaction mixture was kept 
stirring for 20 minutes at 0oC. After that N-acetylcysteamine (143 mg, 1.20 mmol) and 4-
DMAP (20 mg, 0.163 mmol) was added to the mixture. The reaction was then moved to 
room temperature stirring for 4 hours. After stirring the reaction is quenched by 5 ml 
water, and extracted by EtOAc 10 ml three times. The organic phase was washed with 
brine and dried over Na2SO4. The solvent was removed under reduced pressure. 
Purification of the residue via HPLC (rt = 14.8 min, estimated yield 4.7 %) gave 3A as a 
yellow oil. 
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HPLC condition: Beckman UltrasphereTM dp 5 μl mmx25 cm, flow rate 2.5 
ml/min, 0.0 - 15.0 min 98.0% water/ 2.0% ACN; 15.0 - 20.0 min 70.0 %/ 30.0 % CAN; 
20.0 -21.0 min 100% ACN; 22.0 -25.0 min 98.0 % water/ 2.0 % ACN.  
1H NMR (500 MHz, Acetonitrile-d3) δ 6.94 (dt, J = 15.5, 6.9 Hz, 1H), 6.56 (s, 1H), 6.21 
(dt, J = 15.5, 1.5 Hz, 1H), 3.52 (q, J = 5.8 Hz, 2H), 3.32 (q, J = 6.5 Hz, 2H), 3.07 – 2.94 
(m, 2H), 2.33 – 2.21 (m, 2H), 1.85 (s, 3H), 1.53 (tt, J = 10.6, 5.6 Hz, 4H) (Figure 5-18). 
HRESIMS m/z 268.1 (calcd for C11H19NO3SNa 268.10). 
EDC-HCl (384 mg, 2.00 mmol) was added to 2B (158 mg, 1.00 mmol) in 2.5 ml 
dichloromethane solution at 0oC under protection of argon. The reaction mixture was kept 
stirring for 20 minutes at 0oC. After that N-acetylcysteamine (143 mg, 1.20 mmol) and 4-
DMAP (20 mg, 0.163 mmol) was added to the mixture. The reaction was then moved to 
room temperature stirring for 4 hours. After stirring the reaction is quenched by 5 ml 
water, and extracted by EtOAc 10 ml three times. The organic phase was washed with 
brine and dried over Na2SO4. The solvent was removed under reduced pressure. 
Purification of the residue via HPLC (rt = 16.9 min, estimated yield 44.4 %) gave 3B as a 
yellow oil. 
HPLC condition: Beckman UltrasphereTM dp 5 μl mmx25 cm, flow rate 2.5 
ml/min, 0.0 - 15.0 min 98.0% water/ 2.0% ACN; 15.0 - 20.0 min 70.0 %/ 30.0 % CAN; 
20.0 -21.0 min 100% ACN; 22.0 -25.0 min 98.0 % water/ 2.0 % ACN.  
1H NMR (400 MHz, Chloroform-d) δ 6.92 (dt, J = 14.2, 6.8 Hz, 1H), 6.13 (d, J = 15.5 
Hz, 1H), 6.02 (s, 1H), 3.83 – 3.78 (m, 1H), 3.47 (q, J = 5.8 Hz, 2H), 3.08 (t, J = 6.3 Hz, 
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2H), 2.26 – 2.20 (m, 2H), 1.98 (s, 3H), 1.68 – 1.56 (m, 2H), 1.55 – 1.38 (m, 4H), 1.19 (d, 
J = 6.2 Hz, 3H) (Figure 5-19). 
HRESIMS m/z 282.1 (calcd for C12H21NO3SNa 282.11). 
EDC-HCl (44 mg, 0.229 mmol) was added to 2C (33 mg, 0.229 mmol) in 2 ml 
dichloromethane solution at 0oC. After that N-acetylcysteamine (40 mg, 0.336 mmol) and 
4-DMAP (4 mg, 0.036 mmol) was added to the mixture. The reaction was then moved to 
room temperature stirring overnight. After stirring the reaction is quenched by 4 ml 
saturated (NH4)2SO4 solution. The aqueous phase was extracted by dichloromethane 5 ml 
twice. The organic phase was combined, washed with saturated sodium bicarbonate and 
dried over Na2SO4. The solvent was removed under reduced pressure. Further purification 
of the fraction via HPLC (rt = 18.0 min, estimated yield 31.0 %) gave mainly 3C as a 
yellow oil. 
HPLC condition: Beckman UltrasphereTM dp 5 μl mmx25 cm, flow rate 2.5 
ml/min, 0.0 - 15.0 min 98.0% water/ 2.0% ACN; 15.0 - 20.0 min 70.0 %/ 30.0 % CAN; 
20.0 -21.0 min 100% ACN; 22.0 -25.0 min 98.0 % water/ 2.0 % ACN.  
1H NMR (400 MHz, Chloroform-d) δ 3.99 – 3.91 (m, 1H), 3.79 (dddd, J = 10.7, 8.4, 4.5, 
2.1 Hz, 1H), 3.50 – 3.38 (m, 3H), 3.05 (td, J = 6.2, 2.5 Hz, 2H), 2.79 (dd, J = 14.8, 8.4 
Hz, 1H), 2.61 (dd, J = 14.7, 4.5 Hz, 1H), 1.97 (s, 3H), 1.87 – 1.80 (m, 1H), 1.55 (dtdd, J 
= 19.8, 16.8, 7.3, 5.3 Hz, 4H), 1.38 – 1.30 (m, 1H) (Figure 5-20). 
HRESIMS m/z 268.1 (calcd for C11H19NO3SNa 268.10). 
EDC-HCl (261 mg, 1.36 mmol) was added to rac-2D (215 mg, 1.36 mmol) in 10 ml 
dichloromethane solution at 0oC. After that N-acetylcysteamine (232 mg, 1.95 mmol) and 
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4-DMAP (24 mg, 0.214 mmol) was added to the mixture. The reaction was then moved 
to room temperature stirring overnight. After stirring the reaction is quenched by 8 ml 
saturated (NH4)2SO4 solution. The organic phase was washed with brine and dried over 
Na2SO4. The solvent was removed under reduced pressure. The reaction mixture was first 
separated by a CuSO4 contained silica-gel column. Further purification of the fraction via 
HPLC (rt = 18.0 min, estimated yield 51.0 %) gave mainly rac-3D as a yellow oil. 
Column condition: 1x5 cm.  
Eluant: 60 ml (1:2 EtOAc-hexane), then 60 ml (1:1 EtOAc-hexane). 
HPLC condition: Beckman UltrasphereTM dp 5 μl mmx25 cm, flow rate 2.5 ml/min, 0.0 - 
15.0 min 98.0% water/ 2.0% ACN; 15.0 - 20.0 min 70.0 %/ 30.0 % CAN; 20.0 -21.0 min 
100% ACN; 22.0 -25.0 min 98.0 % water/ 2.0 % ACN.  
1H NMR (400 MHz, Chloroform-d) δ 5.82 (s, 1H), 3.84 – 3.75 (m, 1H), 3.49 – 3.40 (m, 
3H), 3.09 – 2.98 (m, 2H), 2.82 (dd, J = 14.8, 7.7 Hz, 1H), 2.67 – 2.53 (m, 1H), 1.96 (d, J 
= 5.0 Hz, 3H), 1.85 – 1.78 (m, 1H), 1.62 – 1.45 (m, 3H), 1.22 – 1.17 (m, 2H), 1.14 (d, J = 
6.2 Hz, 3H) (Figure 5-21). 
HRESIMS m/z 282.1 (calcd for C12H21NO3SNa 282.11). 
Activity assays 
All enzyme reactions were incubated with 15 mM substrate overnight in 150 mM 
NaCl and 20 mM HEPES pH 7.5 at 5 mg/mL enzyme concentration.  After incubation, 
samples were 3X extracted in ethyl-acetate, evaporated and brought up in 50 µL 
methanol prior to being submitted for LC-MS analysis (Agilent 6120 Quadrupole ESI in 
the positive mode equipped with an Agilent 1260 HPLC system). 
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Figure 5-1: Pyran synthase domains in trans-acyltransferase polyketide synthases.  
(A)  Selected trans-AT polyketides containing pyran synthase derived pyran rings.  Gray 
arrows denote pyran rings generated by embedded pyran synthase domains.  
(B)  Domain organization of modules 6-8 of the sorangicin synthase. KS = ketosynthase, 
KR = ketoreductase, KS0 = condensation incompetent ketosynthase, DH = dehydratase, 
DH0 = olefin isomerase, PS = pyran synthase.  
(C) Domain activity immediately preceding SorPS9. 
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Figure 5-2:  Structure of SorPS9.   
(A) Overall structure of SorPS9 (left).  2F0-FC omit map of SorPS9 active site conserved 
active site residues.  
(B) Stereodiagram of SorPS9 active site (cyan) overlayed with trans-AT dehydratase 
domain RzxB (Salmon - PDB: 5IL6) and trans-AT enoyl-isomerase domains PksEI16 
(orange – PDB:4U3V). 
 
 
 
 161 
 
 
Figure 5-3:  Structural overlay of SorPS9 with homologous domains.  
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Figure 5-3 continued; 
Comparison of SorPS9 (teal: PBD 6B2V) with trans-AT dehydratase RzxBDH (salmon: 
PDB 5IL6), Enoyl-isomerase PksEI16 (orange: PDB 3U3V) N-terminal dehydratase 
DifDH11 (green: PDB 4KKU) and cis-AT dehydratase EryDH5 (yellow: PDB 3IL6).  
In addition to mutation and rearrangement of catalytic dyad residues, structural variation 
between these domains is concentrated around the N-terminus as well as the b- sheets 
behind the active site histidine residue. 
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Figure 5-4:  Pyran synthase sequence alignment. 
Sequence and structural comparison of pyran synthase (PS), dehydratase (DH) and enoyl-
isomerase (EI) domains.  Top depicts secondary structure of SorPS9, bottom depicts 
secondary structure of trans-AT DH RzxhDH (PDB: 5IL6). Red asterisk indicates  
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Figure 5-4 continued; 
universally conserved catalytic histidine. Black asterisk indicates additional active 
residue completing catalytic dyad: N/H in PS, D in DH, N in EI. 
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Figure 5-5:  Multiple sequence of trans-AT pyran synthase domains.   
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Figure 5-5 continued; 
Common domain alterations compared to the dehydratase progenitor include a truncation 
to the HX8P motif that follows the catalytic histidine (red asterisk) and substitution of DH 
active site aspartate, generally for an asparagine. 
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Figure 5-6:  Clustal-omega alignment of PS preceeding KR structural subdomains. 
Asterisk denotes diagnostic aspartate indicative of B-type ketoreduction. Dif_KR4(A-
type), Pks_KR3(A-type) and Pks4 (B-type)  included as reference, all other sequences 
precede a PS domain. 
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Figure 5-7: Clustal-omega alignment of PS, DH and EI domains. 
 
Clustal-omega pyran synthase (PS), dehydratase(DH), di-ene-isomerase(DH0) and enoyl-
isomerase (EI) domains.  Red asterisk denotes active site histidine. Black asterisk denotes  
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Figure 5-7 continued; 
conserved proline of DH HX8P motif. Orange asterisk denotes catalytic dyad residue 
(aspartate in DH, histidine/asparagine in PS, asparagine in EI, cysteine in DH0). 
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Figure 5-8: Absorbance characteristics of SorPS9 reaction products.   
After incubation with SorPS9, the absorbance profile of the product shifted compared 
with that of substrate 1 from 268 nm to 234 nm. 
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Figure 5-9:  SorPS9 reverse reaction.  
SorPS9 was incubated with unsubstituted pyran, substituted pyran, and unsubstituted 
substrate (left middle and right columns, respectively) with conversion only being 
observed for the reaction moving in the biosynthetic direction. 
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Figure 5-10:  SorPS9 activity assays and mutagenesis.  
 LC-MS analysis of SorPS9 and active site mutants with (E)-7-hydroxyhept-2-enethioc-
SNAC (left) and racemic (E)-7-hydroxyoct-2-enethioic-SNAC (right) with extracted m/z 
of 268 and 282, respectively. 
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Figure 5-11:  SDS-PAGE gel of SorPS9 and active site mutants.  
Protein was purified via nickel-affinity chromatography followed by gel-filtration into 
low salt buffer. MW of SorPS9 = 31 KDa. 
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Figure 5-12: Proposed Mechanism of Pyran Ring Formation. 
 (A) Proposed mechanism of SorPS9 pyran ring formation. C-O bond formation is 
facilitated by H-bond of N186 with substrate hydroxyl prior to proton abstraction by H33.  
Backbone amide of A39 creates oxy-anion hole to stabilize thioester polarization.  
Subsequent collapse of oxy-anion intermediate regenerates SorPS9 active site.  
(B) Modelling of substrate and product mimics into active highlights probable key ligand 
interactions with His33, Asn186 and backbone amide of A39.  
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Figure 5-13: Pyran synthase substrate reagents. 
Reagents (1A and 1B) used in synthesis of pyran synthase substrates and standards (2A-
2D and 3A-3D). Refer to Substrate Synthesis section of Methods section for further 
information. 
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Figure 5-14: 1H NMR of substrate 2A. 
 (400 MHz, Chloroform-d) δ 7.06 (dt, J = 15.6, 6.9 Hz, 1H), 5.83 (dt, J = 15.6, 1.6 Hz, 
1H), 3.66 (t, J = 6.1 Hz, 2H), 2.26 (qd, J = 7.1, 1.5 Hz, 2H), 1.72 – 1.46 (m, 4H). 
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Figure 5-15: 1H NMR of substrate 2B. 
1H NMR (400 MHz, Chloroform-d) δ 7.07 (dt, J = 15.6, 6.9 Hz, 1H), 5.84 (dq, J = 15.6, 
0.9 Hz, 1H), 3.82 (q, J = 6.1 Hz, 1H), 2.26 (td, J = 6.9, 1.4 Hz, 2H), 1.67 – 1.54 (m, 1H), 
1.57 – 1.42 (m, 3H), 1.30 – 1.17 (m, 3H). 
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Figure 5-16: 1H NMR of substrate 2C. 
1H NMR (400 MHz, Chloroform-d) δ 4.00 (dt, J = 11.5, 2.2 Hz, 1H), 3.78 – 3.68 (m, 
1H), 3.48 (td, J = 11.5, 2.9 Hz, 1H), 2.54 (dd, J = 15.5, 8.0 Hz, 1H), 2.46 (dd, J = 15.5, 
4.8 Hz, 1H), 1.84 (ddd, J = 11.3, 5.7, 2.3 Hz, 1H), 1.71 – 1.45 (m, 4H), 1.41 – 1.28 (m, 
1H). 
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Figure 5-17: 1H NMR of substrate rac-2D. 
1H NMR (400 MHz, Chloroform-d) δ 3.77 (dtt, J = 10.8, 5.4, 2.4 Hz, 1H), 3.55 (ddd, J = 
11.1, 6.3, 1.9 Hz, 1H), 2.61 – 2.44 (m, 2H), 1.68 – 1.47 (m, 4H), 1.30 – 1.22 (m, 2H), 
1.20 (dd, J = 6.2, 3.8 Hz, 3H). 
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Figure 5-18: 1H NMR of substrate 3A. 
1H NMR (500 MHz, Acetonitrile-d3) δ 6.94 (dt, J = 15.5, 6.9 Hz, 1H), 6.56 (s, 1H), 6.21 
(dt, J = 15.5, 1.5 Hz, 1H), 3.52 (q, J = 5.8 Hz, 2H), 3.32 (q, J = 6.5 Hz, 2H), 3.07 – 2.94 
(m, 2H), 2.33 – 2.21 (m, 2H), 1.85 (s, 3H), 1.53 (tt, J = 10.6, 5.6 Hz, 4H). 
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Figure 5-19: 1H NMR of substrate 3B. 
1H NMR (400 MHz, Chloroform-d) δ 6.92 (dt, J = 14.2, 6.8 Hz, 1H), 6.13 (d, J = 15.5 
Hz, 1H), 6.02 (s, 1H), 3.83 – 3.78 (m, 1H), 3.47 (q, J = 5.8 Hz, 2H), 3.08 (t, J = 6.3 Hz, 
2H), 2.26 – 2.20 (m, 2H), 1.98 (s, 3H), 1.68 – 1.56 (m, 2H), 1.55 – 1.38 (m, 4H), 1.19 (d, 
J = 6.2 Hz, 3H) 
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Figure 5-20: 1H NMR of substrate 3C. 
1H NMR (400 MHz, Chloroform-d) δ 3.99 – 3.91 (m, 1H), 3.79 (dddd, J = 10.7, 8.4, 4.5, 
2.1 Hz, 1H), 3.50 – 3.38 (m, 3H), 3.05 (td, J = 6.2, 2.5 Hz, 2H), 2.79 (dd, J = 14.8, 8.4 
Hz, 1H), 2.61 (dd, J = 14.7, 4.5 Hz, 1H), 1.97 (s, 3H), 1.87 – 1.80 (m, 1H), 1.55 (dtdd, J 
= 19.8, 16.8, 7.3, 5.3 Hz, 4H), 1.38 – 1.30 (m, 1H). 
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Figure 5-21: 1H NMR of substrate 3D. 
1H NMR (400 MHz, Chloroform-d) δ 5.82 (s, 1H), 3.84 – 3.75 (m, 1H), 3.49 – 3.40 (m, 
3H), 3.09 – 2.98 (m, 2H), 2.82 (dd, J = 14.8, 7.7 Hz, 1H), 2.67 – 2.53 (m, 1H), 1.96 (d, J 
= 5.0 Hz, 3H), 1.85 – 1.78 (m, 1H), 1.62 – 1.45 (m, 3H), 1.22 – 1.17 (m, 2H), 1.14 (d, J = 
6.2 Hz, 3H). 
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Data collection SorPS8 
Wavelength (Å) 1.0332 
Space group P 61 2 2 
Cell dimensions  a, b, c (Å) 75.37 75.37 195.87 
Resolution (Å) 30.96  - 1.55 (1.61  - 1.55) 
Rmerge 0.064(0.422) 
I/σ(I) 37.1(2.7) 
No. of reflections 47028 (4385) 
Completeness (%) 96.75 (91.97) 
Redundancy 18.8(13.9) 
Wilson B value (Å2) 16.27 
Refinement   
Resolution (Å) 1.55 
No. of reflections 47024 (4385) 
Rwork/Rfree 0.200/0.211 
No. of atoms  
   Protein 2057 
   Water 305 
Average B factors (Å2)  
   Protein 21.2 
   Water 32.71 
RMS deviations  
   Bond lengths (Å) 0.028 
   Bond angles (°) 1.91 
Ramachandran Statistics (%)  
   Preferred Regions 96.98 
   Allowed Regions 2.64 
   Outliers 0.38 
Clashscore 3.2 
Values in parentheses are for highest-resolution shell. 
 
 
Table 5-1:  SorPS9 data collection and refinement statistics. 
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DW469 SorPS9_F	 gcctggtgccgcgcggcagccatATGGGAGAGGTGCGCCAGC	
DW470 SorPS9_R	 tctcagtggtggtggtggtggtgtcaCGCCGCTGGCTTCTCGG	
DW504 SorPS9_H33A_F_GibsonSDM	 CGGAGCCTTTCCTGATGGATGCCGAGCAGCTGTTTCCGGCGG	
DW505 SorPS9_H33A_R_GibsonSDM	 CCGCCGGAAACAGCTGCTCGGCATCCATCAGGAAAGGCTCCG	
DW506 SorPS9_N186A_F_GibsonSDM	 TCGACCCGAACCTGGGCGCTTCGGTTCTGGTGCCC	
DW507 SorPS9_N186A_R_GibsonSDM	 GGGCACCAGAACCGAAGCGCCCAGGTTCGGGTCGA	
DW508 SorPS9_N186D_F_GibsonSDM	 CCTCGACCCGAACCTGGGCGATTCGGTTCTGGTGCCCGC	
DW509 SorPS9_N186D_R_GibsonSDM	 GCGGGCACCAGAACCGAATCGCCCAGGTTCGGGTCGAGG	
DW511 SorPS9_N186H_F_GibsonSDM	 TCGACCCGAACCTGGGCCATTCGGTTCTGGTGCCC	
DW512 SorPS9_N186H_R_GibsonSDM	 GGGCACCAGAACCGAATGGCCCAGGTTCGGGTCGA	
 
Table 5-2. Primers used in SorPS9 cloning and mutagenesis.   
Lower case nucleotides indicate Gibson overlap regions.  Bold italicized nucleotides 
indicate site directed mutagenesis regions. 
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Chapter 6:  Conclusion 
This work has explored the architecture and function of some of the less 
commonly occurring enzymes within type I polyketide synthases to help build a more 
complete picture of the detailed chemistry utilized by Nature for polyketide 
biosynthesis. This work is part of the continued basic research into these powerful 
enzymes which will ultimately provide the understanding necessary for their competent 
rational programming and engineering custom polyketide production. 
Chapter 2 focused on the activity of embedded methyltransferase domains from 
cis-AT polyketide synthases. The work involved in vitro assays of six excised 
monofunctional MT domains from the gephyronic acid biosynthetic pathway using a 
panel of ACP bound and unbound thioester substrates. The methylation activity of these 
domains was monitored by HPLC and mass spectrometry and unequivocally showed 
that they operate exclusively on β-keto-acyl substrates and not on malonyl substrates as 
had been previously reported for two other cis-AT PKS methyltransferases. The work 
presents compelling evidence that methylation occurs only after KS mediated 
condensation for all canonical MTs within the gephyronic acid pathway, a finding that is 
likely to be general for the majority of other cis-AT MTs. 
Chapter 3 built upon the work of Chapter 2 by investigating methyltransferase 
domains from systems within the poorly understood trans-AT PKS bifurcation. MTs 
from 3 synthases: bacillaene, difficidin and macrolactin were shown to exclusively 
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methylate the α-position of β-keto-acyl substrates as was previously shown for MTs 
from cis-AT systems. Michaelis-Menten kinetic assays were subsequently performed 
with the aforementioned substrates revealing modest kinetic values for the six MTs 
assayed. Slow turnover and Km values in the mM range are not unusual when dealing 
with isolated PKS domains. Despite this, over 72 hr. time scales the MTs converted the 
majority of substrate to the anticipated methylated product. 
 Chapter 4 investigated the split bimodules common among the trans-AT 
synthases. These module splits commonly conform to a bimodular architecture wherein 
a module is split between a C-terminal KS domain and an N-terminal DH domain.  A 
combination of structural biology, bioinformatics and enzymology was used to examine 
the aberrant features that are highly conserved among the split bimodular architecture. 
Structures of KR and DH domain from two split bimodules are presented that exemplify 
the novel structural motifs found with the split dehydrating bimodules providing insight 
into the finer details of the idiosyncrasies of the trans-AT synthases. In contrast to their 
more organized cis-AT counterpart, trans-AT synthases exhibit extensive structural and 
functional deviation including non-canonical chemistry, inactive domains, trans-acting 
components and as is the subject of this chapter modules split across adjacent 
polypeptides.s 
In Chapter 5, a novel type of trans-AT PKS domain, the pyran synthase, 
responsible for the formation of 5 and 6 membered oxygen heterocycles during 
polyketide elongation is characterized. As the primary mechanism for pyran ring 
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formation within trans-AT polyketide synthases, pyran synthase domains are found 
within many polyketide biosynthetic gene clusters.  The work presented in Chapter 5 
reveals the PS domain to be closely related to the canonical DH domain and shows how 
a conserved DH active site histidine has been repurposed for new functionality. The 
high-resolution structure of the pyran synthase domains from the ninth module of the 
sorangicin along with structure guided mutagenesis of key residues suggests a 
mechanism wherein a conserved asparagine stabilizes the oxygen nucleophile of the 
substrate for activation by the histidine leading to ring closure. The structure 
demonstrates how subtle changes to an enzyme can transform it for new catalysis and 
furthers our understanding of atypical chemistry within trans-AT pathways.  
We have unraveled many of the details concerning the chemistry of classical 
PKS pathways such as that seen in the erythromycin synthase but much mystery still 
surrounds the aberrant enzyme architecture and novel chemistry used in polyketide 
biosynthesis, particularly with regard to trans-AT pathways. This lack of understanding 
hinders elucidation of the collinear relationship between synthase and bioactive product 
that makes polyketide systems such attractive engineering targets. This work and future 
work like it will hone our understanding of the enigmatic features ok PKS biology and 
in so doing aid future efforts for engineering these marvelous enzymatic assembly lines 
for production of novel bioactive agents. 
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